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Summary 
This study focused on the development of an analytical method whereby creatinine, creatine and 
caffeine could be determined quantitatively. Urine is the preferred body fluid for the analysis of 
metabolites that the body excretes after administration of medicinal and illicit drugs. The detection 
of these metabolites depends on the volume of water the patient has drunk or, in criminal cases, the 
amount of water the suspect may deliberately add to their urine to dilute it. Creatinine, whose 
concentration in urine has been found to correlate with muscle mass, is chosen as an endogenous 
control substance against which the metabolite concentration is compared. While high performance 
liquid chromatography with ultraviolet detection (HPLC–UV) is commonly selected for the analysis, 
the quality of chromatography is affected by the fact that creatinine, being highly polar, is not 
retained in the reversed-phase columns. Furthermore, urine contains many polar substances that 
elute with the solvent front along with creatinine, thereby grossly affecting HPLC measurements. 
Hydrophilic interaction chromatography (HILIC) is a good alternative, although these methods 
generally require extensive sample preparation.  
 
Direct infusion electrospray ionization mass spectrometry (DI–ESI–MS) is ideally suited to highly 
polar compounds and was selected for this work. Pneumatically assisted ESI is preferred above the 
standard ionization method of atmospheric pressure chemical ionization (APCI) since pneumatically 
assisted ESI disperses the solution into ion-containing aerosol droplets which do not promote online 
conversion of creatinine to creatine.  
 
The objective of this study was to develop a simple and sensitive DI–ESI–MS method for the 
determination of various compounds in urine with creatinine as analytical reference compound and 
internal standard (IS). The analytical method development includes addition of 1-methyl-3-
phenylpropylamine as a primary IS to standard solutions as well as to urine samples, followed by 
direct infusion of the sample into a mass spectrometer to determine the absolute concentrations of 
creatinine, creatine and caffeine. After appropriate instrument conditions were established, linear 
graphs of analyte-IS signal intensity ratios were obtained. The ratio of the concentration of the 
analyte (drug or metabolite) to that of creatinine (as IS) may be used to determine analyte 
concentration in artificial samples and/or urine. This method is not affected by change in fluid 
volume or adulteration of urine samples because the analyte-to-creatinine ratio remains unchanged. 
As part of this study, the developed DI–ESI–MS method was compared with an LC–UV–MS method 
developed for this purpose. 
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Opsomming 
Hierdie studie fokus op die ontwikkeling van ‘n analitiese metode waardeur kreatinien, kreatien en 
kaffeïen kwantitatief bepaal kan word. Uriene is die voorkeur liggaamsvloeistof vir die analise van 
metaboliete wat deur die liggaam, na administrasie van mediese en onwettige middels, uitgeskei 
word. Die deteksie van hierdie metaboliete hang van die volume water af wat die pasiënt gedrink 
het, of in strafbare gevalle, die hoeveelheid water wat verdagtes met opset by hul uriene gevoeg het 
ten einde dit te verdun. Daar is bevind dat die konsentrasie van kreatinien in uriene met spiermassa 
korreleer, derhalwe is kreatinien as ‘n interne kontrolemiddel gekies waarmee die metaboliet-
konsentrasie vergelyk kan word. Hoë-druk vloeistofchromatografie met ultravioletdeteksie (HPLC–
UV) word algemeen vir die analise van kreatinien ingespan, maar die gehalte van die chromatografie 
word deur die hoogs polêre aard van kreatinien beïnvloed en het swak retensie in omgekeerde-
fasekolomme tot gevolg. Bowendien, uriene bevat groot hoeveelhede polêre middels wat saam met 
kreatinien in die oplosmiddelfront elueer en sodoende HPLC-bepalings uitermatig beïnvloed. 
Hidrofiliese interaksiechromatografie (HILIC) is ‘n goeie alternatief, ofskoon omvangryke monster-
voorbereidings algemeen vereis word.  
 
Direkte inspuitelektrosproei-ionisasiemassaspektrometrie (DI–ESI–MS) is ideaal geskik vir hoogs 
polêre stowwe en is vir hierdie studie gekies. Pneumatiese hulp-ESI word bo die standaard ionisasie-
metode van lugdruk chemiese ionisasie (APCI) verkies weens pneumatiese hulp-ESI se vermoë om 
die oplosmiddel in aërosoldruppels wat ione bevat, te versprei – sonder die aanlynomskakeling van 
kreatinien na kreatien.  
 
Die doel van hierdie studie was om ‘n eenvoudige en sensitiewe DI–ESI–MS-metode te ontwikkel 
wat verskeie stowwe in uriene kan bepaal deur kreatinien as analitiese verwysingsmiddel en interne 
standaard (IS) vir die opstelling van ‘n IS-kalibrasiekurwe te gebruik. Die analitiese metode-
ontwikkeling sluit die gebruik van 1-metiel-3-fenielpropielamien as primêre IS in. Die IS word tot 
standaard oplossings en urienemonsters gevoeg, gevolg deur direkte inspuiting van die monster in ‘n 
massaspektrometer om die absolute konsentrasies van kreatinien, kreatien en kaffeïen te bepaal. 
Lineêre kurwes van die seinintensiteitsverhouding van analiet tot IS is verkry na gepaste 
instrumentkondisies vasgestel is. Die verhouding van konsentrasie van die analiet (middel of 
metaboliet) tot dié van kreatinien (as IS) mag gebruik word om die analietkonsentrasie in die 
standaard oplossings en/of urienemonster te bepaal. Die metode word nie deur veranderinge in die 
vloeistofvolume of verwatering van urienemonsters beïnvloed nie, weens die analiet-tot-
kreatinienverhouding wat onveranderd bly. ‘n LC–UV–MS-metode is voorts ontwikkel om die 
ontwikkelde DI–ESI–MS-metode se data te vergelyk. 
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Chapter 1:  
Creatinine – The internal reference compound 
 
1.1 Introduction 
The identification, detection and analysis of the metabolites of new drugs are important for drug 
discovery, for clinical and forensic toxicology as well as for the identification of illicit drug use. Illicit 
drugs are a challenge in South Africa and world-wide as these new drugs are developed continuously 
[1]. It is therefore of great importance to continue developing new methods of analysis and to 
improve those currently available. Numerous analytical methods are employed to determine the 
presence of and to quantify illicit drugs in the human body. Typically, body fluid samples such as 
blood, sweat, saliva and urine are used [2]. 
 
Abuse of drugs has been defined as repetitive use of drugs that results in adverse health 
consequences and social problems. Abuse of drugs often leads to addiction which is a chronic 
disease of the brain. Addiction has the potential to be fatal if untreated. Addiction cannot be cured, 
but can be brought into remission through abstinence from all psychoactive substances along with 
supported recovery [3]. Almost all cases of addiction involve psychoactive drugs which affect the 
brain and central nervous system (CNS). This class of drugs includes opioids, sedative hypnotics, 
stimulants, hallucinogens and recently, performance-enhancing drugs such as steroids. Different 
combinations of drugs may also produce similarly addictive psychological effects. Many drugs like 
opium, morphine, heroin, ecstasy, lysergic acid diethylamide (LSD), methamphetamine and 
marijuana have been classified as illegal only in the last half century [2]. 
 
The reasons for use and abuse of chemical substances vary. Interestingly, progressive levels of drug 
use can be easily defined. They begin with abstinence followed by experimentation and then 
recreational use, drug abuse and finally addiction [3]. Being chemically similar to neurotransmitters 
that occur naturally in the human brain, psychoactive drugs pass through the blood-brain barrier 
that protects the brain from foreign materials. Once in the brain they can stimulate or inhibit certain 
activities, and may block reuptake of the brain’s own neurotransmitters [3]. 
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The poor health and social problems resulting from addiction to illicit drugs include cardiovascular 
complications, impairment of the immune system, neurotoxicity, HIV infection [4] and many other 
physiological effects such as impaired memory, processing speed and executive functions [5], as well 
as detrimental, impulsive behavior and decision-making [6, 7]. 
 
Different body fluid matrices have been used in the analysis of illicit drugs. The most preferred body 
fluid to use for the analysis of metabolites in the body following medicinal administration or illicit 
drug use is urine since taking a urine sample is physically non-invasive. Large volumes of urine can be 
collected [8, 9]. Compared with other biofluids, urine is simply an aqueous matrix which contains 
relatively high concentrations of administered drugs and their metabolites [10]. Furthermore, the 
window for detecting drug abuse with urine often span several days for opiates and cocaine and may 
be up to months for chronic cannabinoid use while it is limited to only 1–2 days with blood testing.  
Limitations of testing urine for drugs include adulteration of samples to reduce concentrations of the 
parent drug that are excreted in urine or its metabolites [9]. 
 
The detection of metabolites in urine often depends on the volume of water the patient has drunk 
or, in criminal cases, on the amount of water deliberately added by the suspect to their urine to 
dilute it [11, 12]. Adulteration problems can be overcome by using creatinine (Crn), a small polar 
metabolite whose concentration in urine has been found to correlate with muscle mass [13-16]. 
Creatinine was used in this work as an endogenous control substance against which concentration 
levels of metabolite of interest can be compared.  
1.2 Creatinine formation in the body  
Creatinine, a product of dehydration of creatine (Cr) (Scheme 1.1), was discovered in 1847 by Liebig 
[17]. 
 
Creatine                                                      Creatinine                                                     
Scheme 1.1. Proposed dehydration of creatine to form creatinine. 
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The exact mechanism of creatine biosynthesis in the body has not yet been fully studied. However, it 
is largely accepted that the mechanism involves formation of guanidinoacetate in the kidneys, which 
is transported by blood to the liver where it undergoes methylation to form creatine as shown in 
Figure 1.1 [17].  
 
 
Figure 1.1. Creatine biosynthesis and formation of creatinine [17].  
 
Endogenously generated creatine is exported from the liver by blood and delivered to the organs 
that require it. Dietary creatine is first absorbed by the intestines and then transported through  
blood to creatine-requiring tissues [17]. A reversible enzyme-catalyzed phosphorylation of creatine 
occurs in these tissues to form phosphorylcreatine (PCr). Excess creatine is degraded into creatinine 
which is subsequently excreted through the kidneys.  High levels of creatine and phosphorylcreatine 
have been detected in skeletal muscles, heart, spermatozoa and photoreceptor cells of the retina 
[17]. It is important to note that all creatinine is excreted as a waste product [17] and none is 
reabsorbed or metabolized in the kidneys. This makes creatinine an ideal reference compound for 
the determination of substance abuse and clinical diagnoses of various diseases [18]. 
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1.3 Role of creatinine in metabolite analyses 
Creatinine is usually produced at a fairly constant rate by the body such that its concentration levels 
correlate with muscle mass. Creatinine is frequently considered to be the best natural internal 
standard for normalizing the excretion of many metabolites in urine. The concentration of 
metabolites and diagnostic markers in urine is commonly corrected based on the urinary creatinine 
concentration [19]. In addition, creatinine is most widely used as a marker of urine dilution and renal 
dysfunction [20]. Elevated creatine-to-creatinine ratio is used as marker for creatine transporter 
deficiency [21]. Other metabolites in urine which are used as diagnostic markers for various medical 
conditions include abnormal concentrations of uric acid and albumin (for hypertension, gouty 
arthritis, pneumonia, kidney damage, renal death and hyperuricemia) [20, 22], guanidinoacetate as 
parameter for urea cycle defects [23, 24], pteridines (neopterine, xanthopterine, isoxanthopterine, 
biopterine) and nucleosides (pseudouridine) as prognostic cancer markers [25-27], and delta-
aminolevulinate (δ-ALA) as index of occupational exposure to lead [28].  
 
Recently, a creatinine range of 300 μg/mL – 3000 μg/mL in urine has been adopted as a criterion for 
specimen acceptance in human biomonitoring studies by the World Health Organization, the 
American Conference of Governmental Industrial Hygienists as well as by the Human Biomonitoring 
Commission of the German Federal Environmental Agency, the Deutsche Forschungsgemeinschaft 
(DFG, German Research Foundation) [29]. The normal amount of creatinine in urine, approximately 
900–1500 μg/mL, is used as an exclusion criterion for deciding on artificially diluted or concentrated 
samples [26, 29]. 
1.4 Separation and detection methods applicable to urinary creatinine 
The most recent review of separation methods applicable to urinary creatinine was conducted by 
Smith-Palmer in 2002 [30]. Since the Smith-Palmer review however, many developments and 
improvements have been reported. Further updates to the Smith-Palmer review are therefore given 
here to highlight the general direction of creatinine-based analyses. This section is presented as a 
background to the new direct infusion mass spectrometry method discussed in the following two 
chapters. 
 
Stellenbosch University  http://scholar.sun.ac.za
 5 
 
1.4.1 Classical Jaffé reaction 
 
The Jaffé method [31] is most often employed for the determination of urinary creatinine 
concentration. Creatinine reacts with picric acid under alkaline conditions and forms an orange-red-
colored complex which is detected spectrophotometrically. This reaction is, however, not very 
specific and prone to interferences by a variety of metabolites in urine, such as glucose, fructose, 
ketone bodies, ascorbic acid, and cephalosporins [8]. Many studies employ the Jaffé reaction, or 
colorimetric methods based on the Jaffé reaction, as a comparison to the developed methods for 
validation purposes [29, 32-36]. 
 
1.4.2 Electrochemical biosensors 
 
Enzymatic methods have been developed to enhance specificity in determining creatinine 
concentration. A three-enzyme method in which creatininase (CA), creatinase (CI), and sarcosine 
oxidase (SOx) are used to catalyze the hydrolysis of creatinine producing hydrogen peroxide which is 
detected amperometrically has been reported [37]. The three reactions are shown below. 
 
creatinine + H2O             creatine 
creatine + H2O             sarcosine + urea 
sarcosine + H2O + O2             glycine + H2CO + H2O2 
 
The catalyzed hydrolysis of creatinine producing ammonia by creatinine iminohydrolase has also 
been reported, in which the ammonia was detected potentiometrically [38]. The disadvantages of 
the more creatinine-specific enzymatic methods are the complex immobilization procedures, high 
cost and the instability of reagents. Mimetic biosensors have also been developed by designing and 
synthesizing molecularly imprinted polymers (MIP) for creatinine. Sreenivasan and Sivakumar 
prepared the first MIP for creatinine determination in 1997 [39], after which many investigations 
into preparation of MIP for creatinine ensued [40-45]. 
 
1.4.3 High performance liquid chromatography 
 
The analysis of urinary creatinine has been performed by an array of high performance liquid 
chromatography (HPLC) methods, including reversed-phase HPLC on a range of different stationary 
SOx 
CI 
CA 
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phases, reversed-phase ion-pair chromatography, and ion-exchange columns as discussed in the 
review by Smith-Palmer [30]. In this work, the focus is on reversed-phase HPLC and hydrophilic 
interaction chromatography (HILIC).  
 
1.4.3.1 Reversed-phase HPLC 
 
Reversed-phase HPLC is still used widely for the isolation and quantitation of creatinine in 
conjunction with various other metabolites, such as methotrexate and several pteridines [26], uric 
acid [19], tryptophan and tryptophan-related metabolites [46].  
 
Durán Merás et al. [26] described the chromatographic separation of creatinine, methotrexate, 
neopterine, biopterine, pterine-6-carboxylic acid, and isoxanthopterine on a 3.9  150 mm (5 μm 
particle size) C18 Nova-Pack column with a 8 min isocratic elution program (1.000 mL/min flow rate) 
and a mobile phase consisting of 15 mM tris(hydroxymethyl)aminomethane (Tris) and 1 mM sodium 
chloride (NaCl) (pH 6.8). Creatinine was photometrically detected by ultraviolet (UV) absorbance at 
230 nm and the rest of the metabolites were detected fluorimetrically with excitation at 280 nm and 
emission at 444 nm. The two detectors were in series. Creatinine eluted at 1.85±0.01 min with all 
the metabolites eluting within 7 min. The limit of detection (LOD) was 3.69 μg/mL for creatinine. 
 
Creatinine and uric acid in human urine were determined by Zuo et al. [19] by employing a 
symmetry C18 reversed-phase column (3  150 mm, 5 μm) fitted with a 10 mm C18 guard column 
with a solvent gradient elution program that consisted of sodium phosphate buffer (eluent A), pH 
4.75, and acetonitrile (eluent B). The analysis time was 10 min with a flow rate of 0.450 mL/min for 
the first 3.5 min and increased to 0.500 mL/min for the remainder of the elution. Absorbance was 
measured at 205 nm. Samples were diluted 100-fold with distilled water and an acid precipitation of 
protein with phosphorous acid at pH 2.35 was employed before injection. Creatinine (2.970±0.031 
min), uric acid and hypoxanthine (internal standard) eluted within 6 min of injection and a LOD of 
0.045 μg/mL for creatinine was reported. 
 
Zhao et al. [46] reported the separation of urinary creatinine, tryptophan, kynurenine, kynurenic 
acid, and 5-hydroxyindole-3-acetic acid. A 4.6  250 mm (5 μm particle size) Agilent HC-C18 column 
was used and a 30 min gradient elution program at a constant flow rate of 1.000 mL/min and 
ambient temperature. The mobile phase consisted of eluent A (20 mM sodium acetate, 30 mM 
acetic acid and 3% methanol) and eluent B (20 mM sodium acetate/acetic acid, 10% methanol and 
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10% acetonitrile).  Creatinine, kynurenine and kynurenic acid were measured with a variable 
wavelength detector (VWD) at 258 nm, 365 nm (at 9 min) and 344 nm (at 14 min), respectively. 
Tryptophan and 5-hydroxyindole-3-acetic acid were fluorimetrically determined with excitation at 
295 nm and emission at 340 nm. Urine samples were diluted five-fold before injection. The LOD for 
creatinine was 0.2 μg/mL with a retention time (Rt) of 4.18±0.00 min.  
 
All three methods have time-consuming sample preparation procedures, although the HPLC analysis 
in the first two methods for the simultaneous determination of creatinine and the other metabolites 
are fast. Analysis of the last method is complicated by the characteristics of the compounds. Zuo et 
al. [19] reported the lowest LOD for creatinine. 
 
1.4.3.2 HILIC 
 
A HILIC method was developed for simultaneous determination of urinary creatinine and uric acid by 
Zuo et al. [20] with cimetidine as internal standard. Urine samples were diluted 100-fold after which 
protein precipitation, centrifugation and filtration were carried out. Isocratic elution was used for 
separation on a S5NH2 column (4.6  250 mm, 5 μm) with an NH2 guard column (4.6  7.5 mm, 5 μm) 
within 6 min at a flow rate of 1.200 mL/min and UV detection measured at 205 nm. The mobile 
phase consisted of 50% acetonitrile and 50% 10 mM sodium phosphate buffer solution (pH 4.75). 
Creatinine eluted at 3.08±0.01 min. The LOD was 0.04 μg/mL for creatinine and 0.06 μg/mL for uric 
acid. This method proved to be fast, accurate and reliable as well as being simple and robust when 
compared with reversed-phase HPLC methods. 
 
1.4.4 Tandem mass spectrometry 
 
1.4.4.1 Direct infusion tandem mass spectrometry 
 
Hušková et al. [36] used isotope dilutions for the analysis of urinary creatinine with a d3-labeled 
isomer as the internal standard. Two methods were evaluated, one analyzing samples without 
pretreatment (WP-TMS method) and one after solid-phase extraction (SPE) cation-exchange clean-
up (SPE-TMS method). The LOD for creatinine was 0.2 μmol/L (22.6 ng/mL) for both methods. 
 
Stellenbosch University  http://scholar.sun.ac.za
 8 
 
1.4.4.2 Liquid chromatography tandem mass spectrometry 
 
Park et al. [47] performed a liquid chromatography tandem mass spectrometry (LC–MS/MS) analysis 
on a XTerra MS C18 column (2.1  30 mm, 3.5 μm) and an eluent consisting of 50% acetonitrile and 
0.1% formic acid with a flow rate of 0.300 mL/min at ambient temperature. The ion transitions at 
mass-to-charge (m/z) ratios of 114.0 → 44.0, were monitored in multiple reaction monitoring 
(MRM) mode. This method had a LOD of 1 ng/mL for creatinine. 
 
Isotope dilution electrospray tandem mass spectrometry, using d3-labeled creatinine as the internal 
standard, has been used for the simultaneous separation of urinary creatinine and uric acid [35]. A 
multi-mode ODS column (2  75 mm, 3 μm) fitted with a guard column (2  5 mm, 3 μm) was used 
with the mobile phase consisting of 0.2% formic acid (eluent A) and acetonitrile (eluent B) at a flow 
rate of 0.150 mL/min. The total analysis time was 11 min with creatinine eluting at 1.20 min. The 
HPLC system was coupled to a QTrap triple-quadrupole mass spectrometer with electrospray 
ionization (ESI) operated in positive mode for creatinine and negative mode for uric acid analysis. 
Detection was carried out in MRM mode using the ion transitions (114.0 → 86.0 and 114.0 → 44.0 
m/z) and (166.9 → 124.1 and 166.9 → 95.9 m/z) for creatinine and uric acid, respectively. The 
sample preparation involved centrifugation of the urine samples to obtain clear supernatants at 50 
000 g for 3 min. The samples were diluted 40-fold with distilled water after which it was diluted 
again three-fold with the internal standard solution and acetonitrile. The solution was filtered before 
injection for LC–MS/MS analysis. A LOD of 30 ng/mL for creatinine was obtained. 
 
A HILIC method by Goucher et al. [48] involved the simultaneous extraction, separation and 
detection of creatinine and the opioid methadone, as well as methadone’s primary metabolites (2-
ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline) in 
human urine. SPE was performed prior to HPLC analysis and the total runtime was 3 min. An amide-
80 (4.1  250 mm, 3 μm) HILIC carbamoyl phase column with an isocratic mobile phase containing 
28% (v/v) acetonitrile (with 0.01% formic acid) and 72% 3 mM ammonium formate in water (with 
0.01% formic acid) and a flow rate of 0.250 mL/min was used. MS/MS analysis was performed in 
positive ESI and MRM mode. The ion transition 114.3 → 44.6 m/z was used for quantification. The Rt 
was 1.81±0.6 min for creatinine with a LOD of 0.250 ng/mL. 
 
Very low LODs are obtained with MS/MS analyses compared with HPLC. This is a clear indication of 
the sensitivity of MS detectors. 
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1.4.5 Gas chromatography mass spectrometry 
 
The analysis of creatinine by gas chromatography (GC) requires the derivatization of the compound 
to facilitate their movement through the column. Isotope dilution gas chromatography mass 
spectrometry (GC–MS) methods have been established for the analysis of urinary creatinine alone 
[29] and in conjunction with guanodinoacetate [23] and creatine [49]. 
 
Creatinine was derivatized with bis(trimethylsilil) tri-fluoroacetamide and the ion was measured at 
258 m/z in the method employed by Arias et al. [23]. MacNeil et al. [49] determined the 
concentrations of creatinine and creatine by HPLC and performed separation of the two compounds 
with cation-exchange chromatography after which each fraction was derivatized with trifluoroacetic 
anhydride to determine the ratios of creatinine:creatinine-d3 and creatine:creatine-d3 by GC–MS 
analysis. A new GC–MS method was reported by Tsikas et al. [29] for the quantitative determination 
of creatinine in human urine. The derivatization reagent 2,3,4,5,6-pentafluorobenzyl bromide was 
used to derivatize creatinine and selected-ion monitoring of 112 m/z was performed. The LOD was 
reported to be 100 amol. 
 
1.4.6 Capillary electrophoresis 
 
Analysis of creatinine by capillary electrophoresis (CE) and microchip capillary electrophoresis (μCE 
chip) has enjoyed considerable attention over the past 10 years. The advantages attributed to CE are 
high separation efficiency, fast analysis speed, multiple separation modes, and excellent 
biocompatibility. The analysis of complex matrices such as urine requires pretreatment procedures 
to suppress interferences. These procedures are tedious and time-consuming [50]. Simultaneous 
analysis of creatinine and other compounds such as creatine, guanidinoacetic acid, uric acid, p-
aminohippuric acid, serotonin, and nucleosides in human urine have been performed.  
 
Costa et al. [51] analyzed creatinine in urine (20-fold dilution) in 22 s, using a buffer composed of 10 
mM Tris and 20 mM 2-hydroxyisobutyric acid at pH 3.93. Separation was performed on a fused-silica 
capillary (8.5 cm effective length), with direct UV detection at 215 nm. Simultaneous separation and 
detection of creatinine, creatine and guanidinoacetic acid was reported by Zinellu et al. [52] using an 
uncoated fused-silica capillary (50 cm effective length) and a 75 mM Tris buffer (pH 2.25) at 15°C 
with a 30 kV applied voltage. The separation was completed within 8 min with detection of the 
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compounds by a spectrophotometer. Urine samples were diluted 20-fold with water before 
injection.  
 
Szymaoska et al. [34] applied an extensive SPE procedure to undiluted urine samples in order to 
separate 13 nucleosides. Separation was conducted in a fused-silica capillary (70 cm effective length) 
with a background solution containing 100 mM borate, 72 mM phosphate and 160 mM sodium 
dodecyl sulphate (SDS), pH 6.7, at 30°C with a 25 kV separation voltage applied to the capillary. The 
nucleosides and creatinine were detected spectrophotometrically. The analysis was completed after 
26 min. Creatinine was separately analyzed under the same conditions with a migration time of 10 
min. Jiang and Ma [53] reported a dramatically reduced separation time of 7.5 min for ten modified 
nucleosides in urine samples. Creatinine was also analyzed separately. Electrophoretic separation 
was achieved in a fused-sillica capillary (38 cm effective length) at –15 kV applied voltage and 25°C 
with a buffer, which contained 25 mM borate, 25 mM phosphate and 25 mM cetyltrimethyl-
ammonium bromide at pH 9.5. 
 
A serial ultrasound-assisted emulsification microextraction procedure for urine pretreatment was 
employed by Huang et al. [50] to analyze creatinine and serotonin. The separation was concluded 
after 15 min migration time on a 48 cm effective length fused-silica capillary and 30 mM Tris-
phosphate buffer, at pH 2.85, with an applied voltage of 20 kV. The method provided a sensitivity 
enhancement of 360-fold for the detection of serotonin.   
 
Lee and Chen [54] reported the separation of creatinine and uric acid in human urine in 400 s by 
incorporating a multiple-enzyme (CA, CI and SOx) assay into a μCE chip with electrochemical 
detection. Urine samples were diluted ten-fold and filtered before injection. Wang et al. [55] used 
the same enzymatic assay and electrophoretically separated creatinine, creatine, uric acid, and p-
aminohippuric acid and amperometrically detected reaction products. Application of this method to 
a 50-fold diluted urine sample yielded a separation and detection of creatinine and uric acid within 
400 s, however p-aminohippuric acid was not detected. Garcia et al. [56] described the separation of 
creatinine, creatine and uric acid in a urine sample (20-fold dilution) within 150 s by pulsed 
electrochemical detection using a buffer consisting of 30 mM borate (pH 9.4) and 1 mM SDS. 
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1.4.7 Limitations of current methods for creatinine analysis 
 
The limitations of the current methods for analysis of creatinine are summarized in Table 1.1. None 
of these methods directly address the problem of sample adulteration and most require 
cumbersome and time-consuming sample preparation and analysis procedures. 
 
Table 1.1. Limitations of current methods for analysis of creatinine. 
Method Limitation(s) 
Classical Jaffé reaction Non-specific for creatinine 
Electrochemical biosensors Complex immobilization procedures, high cost and instability of 
reagents 
Reversed-phase HPLC Cumbersome and time-consuming sample preparation and analysis 
procedures 
HILIC High cost 
Direct infusion MS/MS - 
LC–MS/MS High cost and time-consuming sample preparation and analysis 
procedures 
GC–MS High cost and time-consuming sample preparation procedures 
(derivitization) 
CE Time-consuming sample preparation and analysis procedures 
 
1.5 Mass spectrometry 
The birth of MS is attributed to Sir Joseph J. Thomson who discovered the electron in 1897 and he 
constructed the first mass spectrometer in 1902 [57].  
 
MS has unique capabilities which have made it widely popular. Firstly, it provides unsurpassed 
molecular specificity because of its unique ability to measure accurate molecular mass. Secondly, it 
provides ultrahigh detection sensitivity. Thirdly, it has unparalleled versatility to determine the 
structures of most classes of compounds and individual elements. Furthermore, it is applicable to a 
large variety of samples, volatile and non-volatile, polar or non-polar. Lastly, it can be applied in 
combination with high resolution separation devices [58]. 
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All mass spectrometers consist of five essential components, namely an inlet, ion source, mass 
analyzer, detector, and data system (Figure 1.2) [58]. It can be arranged in many instrumental 
configurations, each with its specific advantages, limitations and cost-to-benefit ratio. Novel 
ionization methods, mass analyzers and sample pretreatment techniques are continually being 
developed, improved and utilized.   
 
 
Figure 1.2. Essential components of a mass spectrometer. 
 
MS has become one of the most relevant techniques in drug development, profiling of 
metabolomes, clinical and forensic toxicology, analyses of polymers [59] and many more. Due to its 
high sensitivity and specificity, MS hyphenation with chromatographic procedures has proved to be 
invaluable in the analysis of drugs, toxins, and/or their metabolites in complex biological samples 
such as blood or urine, or alternative matrices such as hair, saliva, sweat, or meconium [60, 61]. Both 
LC–MS and GC–MS have become particularly relevant in the detection of illicit drugs [62]. In 
hyphenated cases the MS instrument is used as a detector. In the case of LC–MS the effluent from 
the HPLC column enters the ionization chamber through the ESI needle as shown in Figure 1.3. 
 
 
Figure 1.3. Block diagram for an Agilent quadrupole MS system. 
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The LC–MS set-up allows the identification of the compounds of interest so that they can be 
quantitatively analyzed by the chromatographic technique. However, many analytes require 
pretreatment of the sample in order to make them volatile in the case of GC–MS or to make them 
responsive to light in the case of LC–UV. It should be noted that sample treatment is time 
consuming.  
 
In recent years, advances have been made to conventional MS interfaces such as matrix-assisted 
laser desorption/ionization (MALDI) under vacuum [63, 64] and ESI techniques to allow more direct 
analysis of samples by mass spectrometry. These techniques include atmospheric pressure MALDI 
[65], desorption electrospray ionization (DESI) [66, 67], desorption atmospheric pressure 
photoionization (DAPPI) [68], direct analysis in real time (DART) [69, 70] and desorption sonic spray 
ionization (DeSSI) [71] among others. These approaches still fall short with regard to quantitative 
determination. 
 
1.5.1 Electrospray ionization 
 
ESI is based on the application of high voltage to sample flow to produce small droplets. The 
discovery of electrospray phenomenon can be dated back to 1750, when Jean-Antoine Nollet 
observed that water flowing from a small hole of an electrified metal container forms aerosol when 
placed near the electrical ground [72]. Later, a series of systematic studies on electrospray were 
carried out by Zeleny [73-75] and Taylor [76] allowing a detailed description of the phenomenon. 
Electrospray was mainly put to use as an effective painting technique, but in the 1960s and early 70s 
Dole et al. reported the first use of electrospray as an ion source for mass spectrometry when they 
produced gas-phase, high molecular weight polystyrene ions by electrospraying a benzene/acetone 
solution of the polymer [77, 78]. The latest basic developments of ESI–MS were made by Fenn et al. 
[79-81] for which John B. Fenn received the Nobel Prize in Chemistry in 2002 [82]. 
 
The mechanism of ESI can be described in three main steps. The first step involves the formation of 
charged droplets at the tip of the spray capillary. In conventional ESI, the charging of the droplets is 
due to the action of the applied electric field between the spray capillary tip and a counter 
electrode. A charge separation takes place and an enrichment of ions of the same polarity as that of 
the emitter will occur at the emitter. In pneumatically assisted ESI, co-axial flow of heated nitrogen 
gas is introduced to enhance droplet formation and ionization in the ion source with the spray 
capillary grounded. An electric field is applied between an electrode in the spray chamber and the 
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inlet capillary which serves as the counter electrode. If the field is strong enough, charged droplets 
are directed to the heated capillary inlet and naked ions are formed as the solvent evaporates. This 
ionization phenomenon is strongly enhanced by the presence of hydrogen ions. The eruption of 
charged droplets into naked ions is strongly influenced by the solvent physico-chemical properties 
(viscosity, surface tension, pKa), the concentration and chemical nature of analytes as well as ionizing 
agents i.e. acid, and the voltage applied between inlet capillary and counter electrode [58, 83, 84]. 
 
The second step entails the evaporation of solvent from the droplets. When a charged droplet 
travels towards the counter electrode, its radius decreases as the solvent evaporates, but its charge 
remains constant. Solvent evaporation is achieved by the flow of hot nitrogen, which also heats up 
the spray chamber. Evaporation of the charged droplets is further enhanced by a heated capillary. 
The decrease in droplet radius leads to an increase in surface charge density. At a certain point, 
called the Rayleigh limit, the Coulombic force overcomes the surface tension of the liquid and the 
droplet undergoes irregular fission into several offspring droplets. This so-called Coulombic fission 
can be repeated in several cycles, leading to very small highly charged second-generation droplets 
[58, 83, 84].  
 
The final step is the formation of gas phase ions. The actual mechanism for the transfer from 
solvated ions to gas phase ions is not fully understood and has been under discussion for a long 
time. Two main theories have been suggested: the charged residue model (CRM) and the ion 
desorption model (IDM). Lately it has been suggested that both mechanisms apply. The CRM 
involves a process of repeated sequential solvent evaporation and a series of scissions which lead to 
the production of small droplets containing only one solute molecule. As the last solvent molecules 
on each droplet evaporate, analyte molecules are dispersed into the ambient gas, retaining the 
charge of the droplets. The IDM also relies on the sequence of solvent evaporation and fission of the 
droplets. This model, however, proposes the expulsion of the solvated ions into the gas phase at 
some intermediate droplet size when the electric field due to the surface charge density is 
sufficiently high but less than the Rayleigh instability limit [58, 81, 83, 84]. 
 
The ESI source can lead to the production of positive or negative ions, depending on the polarity of 
voltage applied to the sprayer and the counter electrode [84] or in the case of pneumatically 
assisted ESI with the spray capillary grounded, between an electrode in the spray chamber and the 
inlet capillary. ESI is by far the method of choice in LC–MS metabolomic studies because it produces 
large numbers of ions via charge exchange in solution. The unique formation of molecular ion 
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species in the gas phase makes the ESI method highly interesting for the analysis of complex 
mixtures. If these ions were transferred reproducibly, quantitative analysis by MS would be carried 
out directly without the need of prior chromatographic separation. Through a simple direct infusion 
of the mixture dissolved in a suitable solvent it is possible to obtain relative ratios of the molecular 
species present in the mixture itself. 
 
1.5.2 Mass analyzer 
 
The mass analyzer is the heart of a mass spectrometer. It is a fundamental part which separates and 
mass-analyzes the ionic species according to their mass-to-charge (m/z) ratio and focuses all mass-
resolved ions at a single focal point. The m/z is by definition the mass of an ion (m) divided by the 
number of charges (z) the ion carries. The motion of the ions is controlled by magnetic and/or 
electric fields. The most common forms of mass analyzers include a quadrupole, time-of-flight, 
magnetic sector, orbitrap, quadrupole ion trap, and Fourier transport ion cyclotron resonance 
instrument. A mass analyzer is best defined according to its ion transmission efficiency and mass 
resolution. Ion transmission efficiency involves the ability of a mass analyzer to deliver various ions 
in the entire mass range to the detector. This is also a reflection of the sensitivity of the instrument. 
By definition, mass resolution is the analyzer’s capability to distinguish between two neighboring 
signals of ions that differ only slightly in their mass (Δm) [58, 83]. 
 
The quadrupole mass analyzer is shown in Figure 1.4. It consists of four cylindrical rods that are 
parallel to one another. Direct current (dc) and radio-frequency (rf) potentials are applied to these 
symmetrically arranged rods. The field within the square array is created by alternating voltages 
between opposite pairs of electrodes. The ions accelerated along the z-axis enter the space between 
the rods and maintain their velocity along this axis. Due to the electric field, these ions are also 
accelerated in the x and y-directions. Ions with a specific m/z value pass through the geometry of the 
rods when a set of defined dc and rf potentials are applied because of their stable trajectories. In the 
xz-plane, a positive ion will be accelerated toward the central axis when a positive dc potential is 
applied to the pair of rods in the same plane. The simultaneous action of the rapidly changing rf 
potential during its negative half-cycle will accelerate these ions towards the rods. The positive 
electrodes act as a high-pass filter. The pair of electrodes in the yz-plane is at a negative polarity. The 
positive ions will be attracted toward these rods and during the positive half-cycle of the rf potential 
only the ions with lower m/z will be focused to the central axis. The negative electrodes act as a low-
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pass filter. The combination of these actions creates a stability window for ions of a narrow m/z 
range to travel through the rods in the z-direction [58, 83]. 
 
 
Figure 1.4. Quadrupole mass analyzer. 
 
The low cost, mechanical simplicity, high scan speeds, high transmission, increased sensitivity, 
independence from the initial energy distribution of ions, and linear mass range are advantageous 
attributes of a quadrupole mass analyzer [58]. 
 
1.5.3 Detector 
 
The detector is responsible for converting the ion current into signals. The MS used in this work was 
equipped with the electron multiplier detector. The ions from the mass analyzer are accelerated to a 
high velocity in order to enhance detection efficiency by holding the conversion dynode at a high 
potential (from ±3 to ±30 kV) opposite to the charge polarity of the detected ions. A positive ion 
striking the conversion dynode causes the emission of several electrons. These are then amplified by 
a cascade effect to produce an amplified electric signal [83]. 
 
1.5.4 Direct infusion electrospray ionization mass spectrometry 
 
Direct infusion electrospray ionization mass spectrometry (DI–ESI–MS) is ideally suited to highly 
polar compounds and was selected for this work. Its advantages include high sensitivity, high 
selectivity, wide dynamic range, robustness, and the ability to identify metabolites [85]. In contrast 
to LC, the use of DI–ESI–MS has the greatest potential for high peak capacity and sample throughput 
with minimal or no sample pretreatment. Complex samples can be analyzed without sample 
separation steps [86, 87]. The application of DI–ESI–MS to highly complex and variable samples such 
as urine and plasma/serum where matrix effects are inevitable has a number of challenges. Such 
 
Y 
Z 
X 
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challenges include ion suppression or undesired signal enhancement, and difficulties in separating 
isobaric substances [87, 88]. DI–ESI–MS has been applied in various fields of research, including the 
study of blood plasma metabolites [89], urinary metabolites [90], human metabonomics and 
metabolomics [86-88], fungi and yeast metabolomics [91, 92], secondary metabolites from 
microorganisms [93], fruit and vegetable metabolomics [94-98], food [99, 100], polymers [101], and 
characterization of proteinaceous glues [102]. 
1.6 Aim of this study 
The objective of this study was to develop a simple and sensitive DI–ESI–MS method for the 
determination of various compounds in urine with creatinine as analytical reference compound and 
internal standard (IS) for the construction of an IS calibration curve. When fully developed, this 
method will not be affected by change in fluid volume or adulteration of urine samples because the 
analyte-to-creatinine or analyte-to-creatine ratio remains unchanged.  
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Chapter 2:  
Method development – Quantitative direct infusion 
electrospray mass spectrometry 
 
2.1 Introduction 
Creatinine and creatine are small, highly polar metabolites found in urine. Although these 
compounds have been analyzed with liquid chromatography (LC) and gas chromatography (GC)-
based methods, they are associated with some limitations. In reversed-phase LC, these compounds 
elute with the solvent front while in normal phase, they tend to stick to the stationary phase. Since 
these metabolites are highly polar and typically have very high boiling points, they are unsuitable for 
analysis by GC unless they are chemically derivatized. Other different analytical methods for 
metabolites in urine are limited in that they require extensive sample pretreatment and are in many 
cases quite cumbersome and tedious as evident in the review of Smith-Palmer [30] and the 
discussion in section 1.4.  
 
In this work, a simple and sensitive direct infusion electrospray ionization mass spectrometry (DI–
ESI–MS) method was developed for the detection and quantification of creatinine, creatine (Scheme 
1.1) and caffeine (Scheme2.1). Caffeine was selected as a model compound to represent common 
drugs or drug metabolites that may be analyzed. 
  
           
        Caffeine 
Scheme 2.1. Chemical structure for caffeine. 
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2.2 Experimental procedures 
2.2.1 Materials and methods 
 
All chemical and chromatographic reagents used were of HPLC grade. Creatinine, creatine, caffeine, 
2-phenylbutyric acid, 1-methyl-3-phenylpropylamine (MPPA), methanol and acetic acid were 
purchased from Sigma-Aldrich (St. Louis, Missouri, USA) and were of the highest purity. Millipore 
water (Millipore, Milford, Massachusetts, USA) was used in all solutions and analyses. Mass 
spectrometry (MS) was performed on an Agilent 6120 LC/MSD Single Quad purchased from Agilent 
Technologies (Böblingen, Germany) connected to a N2-Mistral-LCMS nitrogen generator purchased 
from LNI Schmidlin SA (Geneva, Switzerland). The system consists of two regions: (A) Ion source and 
(B) Ion transport and focusing region. The atmospheric pressure ionization source is an ESI source. 
The ion transport and focusing region consists of four stages which are under vacuum: (A) Inlet 
capillary and fragmentation zone; (B) Skimmers; (C) Octopole; (D) Quadrupole mass analyzer and 
electron multiplier detector. All statistical and graphical analyses were performed with SigmaPlot® 
11.0 (Systat Software, Inc., Chicago, Illinois, USA). 
 
2.2.2 Direct infusion mass spectrometry 
 
The determination of concentration of creatinine, creatine and caffeine by ESI–MS involves 
continuous infusion of the analyte solution. The analyte solution enters the needle by gravitational 
force alone, since a pump is not used, ensuring a consistent and reproducible flow speed. The MS 
conditions for the direct infusion analysis are summarized in Table 2.1. 
 
Table 2.1. MS conditions for direct infusion analysis. 
Mass analyzer mode Scan 
Ion polarity mode Positive 
Mass-to-charge range 20–300 m/z 
Capillary voltage -4000 V 
Chamber voltage -3500 V 
Fragmentation voltage 95 V 
Scan time 5 min 
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A schematic diagram of the Agilent 6120 MS instrument, which was used for the direct infusion 
experiments, is shown in Figure 2.1.  
 
 
Figure 2.1. Agilent 6120 Mass Spectrometer. 
 
The analyte solution is continuously introduced by the ESI needle to the ion source in the spray 
chamber which is a high voltage region. The needle is placed inside a larger capillary through which 
nitrogen gas is pumped to nebulize the solution. Upon nebulization the analyte molecules are 
ionized by cations (X+), predominantly H+ ions from solution, forming [M+nX]n+ ions. The charged 
droplets pass across an electric field between the electrode at a higher voltage (-3500 V) relative to 
the heated capillary held at -4000 V. The ions are electrostatically guided and drift towards the 
relatively high negative voltage; in doing so, the ions enter the heated capillary and proceed into the 
analyzer region. Data processing involved multiple scanning of the mass range (20–300 m/z) ions for 
about 5 min to obtain an average mass spectrum with averaged signals for each ion detected. 
 
2.2.3 Construction of calibration curves 
 
Stock solutions containing 1 mg/mL standard were prepared for creatinine, caffeine and MPPA in 
distilled water and stored in a cool, dry place. Dilutions of each standard stock were made with a 
solvent containing 90:7.5:2.5 (% v/v/v) methanol, water and acetic acid. Two sets of calibration 
-3500 
V -4000 
V VV 
-3500 V 
-4000 V 
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curves were constructed. The first set contained creatinine as the analyte and MPPA as primary 
internal standard. The standard mixtures were made in triplicate to contain 1, 2.5, 5, 7.5 and 10 
μg/mL of creatinine, respectively, and each with 5 μg/mL of MPPA, the primary internal standard. 
The second set contained caffeine as the analyte and creatinine as secondary internal standard. The 
standard mixtures were made in triplicate to contain 1, 2.5, 5, 7.5 and 10 μg/mL of caffeine, 
respectively, and each with 5 μg/mL of creatinine, the secondary internal standard. 
 
Triplicate measurements of each standard were made by DI–ESI–MS. Blank runs were performed 
after every measurement to ensure that there was no carry-over between runs. The ratio of the 
absolute counts (abundance) of the m/z signals and the concentration ratio of the analyte (AN) and 
internal standard (IS) were calculated: (CntsAN)/(CntsIS) and CAN/CIS respectively. Calibration curves of 
(CntsAN)/(CntsIS) versus CAN/CIS were constructed. The calibration curves displayed a linear 
relationship over the concentration range of 1–10 μg/mL for the analyte and were fitted with a 
linear equation (given below) by linear regression in SigmaPlot® 11.0. 
 
  Eq. 1 
 
2.2.4 Preparation of unknown and urine sample 
 
The three samples with unknown amounts of creatinine and caffeine were prepared by a laboratory 
at the Department of Biochemistry, Stellenbosch University (Stellenbosch, South Africa). Urine from 
a subject was collected over 24 hours. After each collection, the urine was immediately stored at 
4°C. After 24 hours the collections were pooled and a sample was taken. Before analysis, the 
unknown and urine samples were kept at room temperature for 30 min. 0.5 mL of a 100 μg/mL stock 
solution of the internal standard, MPPA, in distilled water was added to 100 μL of unknown or urine 
sample in a 10 mL volumetric flask. Solvent (90:7.5:2.5 (% v/v/v) methanol, water and acetic acid) 
was added to the mark to obtain a 100-fold dilution. The samples were then ready for DI–ESI–MS 
analysis. 
2.3 Metabolite quantification 
The quantification of urinary metabolites with MS is usually performed by coupling the mass 
spectrometer to another analytical instrument where the mass spectrometer serves as a 
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complementary technique.  In this work quantification with DI–ESI–MS was assessed. Three common 
methods of quantification, namely, external calibration method, standard addition method and the 
internal standard method were considered as discussed below. 
 
2.3.1 External calibration method 
 
External calibration is the most common method determining analyte concentration in a sample. 
The method involves construction of a calibration plot of the instrument response versus 
concentration of standard solutions. The response of an unknown is used to read its concentration 
from the calibration graph. Comparison of the instrument response of a sample directly to that of a 
single standard solution is unreliable. It is therefore of utmost importance that multiple standards 
are used to ensure greater reliability of the results. Analyte concentration in a given sample is 
determined either visually from the graph as a value corresponding to the sample signal or by 
calculation using the equation of the graph [103]. 
 
The external calibration method has several desirable characteristics and is widely used in 
quantitative instrumental analysis. The two most common advantages of external calibration are its 
general applicability and efficiency in routine analyses. Once the calibration graph has been 
prepared, a large number of samples which may vary can be analyzed. However, frequent 
confirmation of readings of the standards is necessary to ensure that the instrument response is 
constant [103]. The greatest disadvantage of external calibration arises from the fundamental 
assumption that the instrument response observed for the standards remains unchanged whenever 
the unknown is measured. Most unknown samples contain a matrix, components not present in the 
standards, which often affect the response. Such matrix components do often give rise to systematic 
error in the results, unless their effect is corrected or they are removed [103]. 
 
2.3.2 The standard addition method 
 
Some analyses are only possible with standard additions. In general, the standard addition method is 
used to eliminate the effects of the sample matrix in the results. The method is carried out by first 
dividing the sample which contains the analyte of interest into several solutions to which a known 
amount of a pure standard is added. The amount of analyte in the unknown (U) sample remains 
constant while the amount of standard (S) added increases proportionally with each increment. The 
equation of the graph (Figure 2.2) is used to determine the intercept, VS’–which corresponds to the 
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negative of the amount of analyte in the original unknown–once the line has been extrapolated to 
the x-value that corresponds to the y-value of zero [103]. The unknown concentration of the analyte 
in the original sample mixture is determined by calculation using equation 2, 
 
U
SS
U
V
VC
C
'
   Eq. 2 
 
where CU is the concentration of the unknown, CS is the concentration of the standard, VS’ is the 
intercept of the x-axis (volume of standard) and VU is the volume of the unknown. 
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Figure 2.2. Typical standard additions plot. 
 
While it allows reduction of the matrix effects on the response of the instrument and thereby 
increasing reliability of the results, the standard addition method is suitable only for non-routine 
analyses. Its calibration plot is good for a given, single sample or set of very similar samples. Further 
limitations include additive matrix effects. The standard addition method is affected greatly by 
fluctuations in instrument response for a given sample and is therefore not suitable for quantitative 
analysis by DI–ESI–MS [103].  
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2.3.3 The internal standard method 
 
The internal standard method, otherwise known as internal standardization, is ideal when variations 
in sample sizes and instrument response are encountered during analysis. The method is similar to 
external calibration in that a series of standards is needed and similar to standard additions in that a 
known amount of a standard is added. The method involves addition of a known quantity of a 
reference compound, the internal standard, in all the standards and the unknown samples analyzed 
for quantification. The response signals for both the analyte and the internal standard are measured 
[103]. 
 
The concentration ratio and the response ratio of analyte to internal standard are calculated for 
each solution. A calibration plot of the response ratio versus concentration ratio is prepared. The 
response ratio is not affected by a variation in the response signals that may vary from sample to 
sample, resulting in a linear plot over a certain range of ratios. Linear regression is performed on the 
resulting plot and a linear least squares (LLS) equation is obtained. After the response ratio for the 
unknown is determined, the LLS equation of the internal standard line is used to calculate the 
corresponding concentration ratio. The known concentration of the internal standard added is 
multiplied by the ratio to obtain the concentration of the unknown [103]. 
 
The internal standard method is ideal for analysis without auto-sampler equipment as it is 
independent of the accuracy of injection. A suitable compound is necessary to ensure the success of 
the internal standard method. The requirements that need to be met by such a compound are that it 
is not present in the unknown, it does not react with anything in the sample matrix, both the analyte 
and the internal standard are affected in the same manner and show similar changes in the 
instrument response. Lastly, the analyte and internal standard should produce separate signals, 
which do not overlap each other or the signals of matrix components. The internal standard method 
is primarily associated with instrumental methods having sharp, narrow output signals, such as mass 
spectrometry [103]. 
 
Considering all the characteristics, the internal standard method is the most promising method in 
the quantification of the urine metabolites by DI–ESI–MS, provided a suitable internal standard 
compound can be identified, and was applied in the quantification of the urine metabolites: 
creatinine, creatine and caffeine in this work. 1-Methyl-3-phenylpropylamine was used as a primary 
internal standard to quantify creatinine. After the concentration of creatinine has been determined, 
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creatinine acts as the secondary internal standard to quantify creatine and caffeine. The 
quantification was achieved by generating calibration curves for the metabolites. 
2.4 Proposed method development strategy 
A useful strategy towards developing a practical method for the simultaneous detection and 
quantification of urine metabolites involved a close study of their chemistry, particularly their 
capacity for ionization and ability to form hydrogen bonds in solution. The chemical behavior of 
these compounds was evident from their mass spectra. 
 
Based on some fundamentals of different methods of quantification and the preliminary 
observations, discussed in chapter 3, key parameters were established which allow direct infusion 
mass spectrometry to be used as proposed. Firstly, to ensure low viscosity and volatility of the 
carrier solvent, methanol was incorporated in the solvent mixture. Since the metabolites to be 
analyzed are highly polar, water was also incorporated. To promote quantitative ionization of the 
analyte molecules into [M+H]+ species, acetic acid was also made part of the solvent carrier for the 
proposed DI–ESI–MS method. The fragmentation voltage which is applied at the skimmer, which is 
part of the ion transfer optics, was used to ensure that the analyte molecules are in the monomeric 
form and not clusters. This is important as it prevents multiplicity of the signals. Furthermore, an 
internal standard method was selected for DI–ESI–MS in view of the associated high level of signal 
intensity variations. The internal standard method was most appropriate in another sense as well. 
The internal standard method allows use of an endogenous metabolite, creatinine, as an internal 
standard for quantitative determination of other urine metabolites. To use creatinine successfully as 
an internal standard, a primary standard is required, which is not a component of urine, so that 
creatinine concentration can be determined against it. For this purpose, 1-methyl-3-
phenylpropylmine was selected. 
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Chapter 3:  
Results and discussion 
 
3.1 Preliminary observations 
Preliminary LC–MS analysis of creatinine (11 μg/mL in deionized water) revealed that creatinine was 
converted online to creatine, and indicated the presence of sodium adducts of both compounds 
(Figure 3.1). A Waters LC–MS Q–TOF instrument used in these preliminary experiments was 
equipped with an atmospheric pressure chemical ionization (APCI) chamber, as shown in Figure 3.2, 
which could facilitate online conversion of creatinine to creatine. More importantly the Waters LC–
MS instrument uses the conventional direct electrospray process for ionization where a high positive 
voltage (2500 to 4500 V) is applied to a metal capillary. In this set-up it has been reported that 
electrochemical reactions may occur which could lead to bond cleavage and hydrolysis. Such a 
process would convert creatinine into creatine. Conventional, direct electrospray ionization mass 
spectrometry was therefore not pursued any further in this work.   
 
 
Figure 3.1. Mass spectrum of creatinine with APCI as the method of ionization. Online conversion of 
creatinine (a) to creatine (b) and sodium adduct formation with both compounds are observed. 
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Figure 3.2. Waters LC–MS Q–TOF Mass Spectrometer. 
 
Further experiments were carried out on the Agilent 6120 LC–MS system which is equipped with a 
pneumatically assisted atmospheric pressure ESI chamber as shown in Figure 2.1. When creatinine 
(10 μg/mL in 90:10 (% v/v) methanol and water) was analyzed, online conversion of creatinine to 
creatine was not observed. The mass spectrum is shown in Figure 3.3. Considering the multiple 
peaks in the mass spectrum which were generated from a single analyte, it was evident that the 
response of creatinine needed to be simplified. As shown in Figure 3.3, four creatinine species 
[M+H]+, [M+Na]+, [2M+H]+ and [2M+Na]+ with m/z of 114, 136, 227 and 249 respectively, were 
observed instead of a single peak, [M+H]+ at  114 m/z. 
  
 
Figure 3.3. Mass spectrum of creatinine with atmospheric pressure ESI as ionization method.  
Online conversion of creatinine (a) to creatine is not observed. Creatinine sodium adduct formation 
occurred and dimerization (b) of both creatinine and the sodium adducts are observed. 
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3.2 Overcoming sodium adduct ion formation  
Although all measures were taken to ensure contamination free equipment were used, sodium 
adduct ions were observed. It is possible that adventitious sodium ions, likely from storage bottles 
and vials or residues due to handling, compete with hydrogen ions in pH-neutral solutions and form 
undesirable sodium adducts [104-106]. The solvent in the creatinine solution consisted of 90:10 (% 
v/v) methanol and water. Acetic acid was added in order to promote the formation of hydrogen-
adduct [M+H]+ ions over sodium adduct [M+Na]+ ions. When a new creatinine solution (10 μg/mL) 
was made up with methanol, water and acetic acid in 90:9.9:0.1 (% v/v/v) ratio and analyzed, signal 
intensities of the two creatinine sodium adduct species, [M+Na]+ and [2M+Na]+, were significantly 
reduced (Figure 3.4).  
 
 
Figure 3.4. Mass spectrum of creatinine with the addition of acetic acid to the solvent. (a) Creatinine; 
(b) creatinine dimer. The availability of an excess amount of hydrogen ions shadow the sodium ions 
present and a reduction in the [M+Na]+, [2M+H]+ and [2M+Na]+ species is observed. 
 
Although a significant decrease in the creatinine dimer species, [2M+H]+ and [2M+Na]+, was 
observed after addition of acetic acid, further reduction of dimer formation required additional 
measures as discussed next. 
3.3 Overcoming creatinine dimerization 
Creatinine molecules, as well as creatine, seem to form hydrogen bonded dimers in solution 
(Scheme 3.1), which survive transition into the gas phase as [2M+H]+ ions. The intermolecular H-
bonds are generally weaker than intramolecular bonds and are disrupted by high voltage applied at 
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the skimmer. Voltage applied at this point of the ion transmission optics is referred to as 
fragmentation voltage as it can cause fragmentation of ordinary compounds when it is set 
sufficiently high. 
 
Scheme 3.1. Proposed chemical structure for a creatinine dimer. Two hydrogen bonds are formed 
between two creatinine molecules to form the dimer. 
 
An experiment was conducted whereby fragmentation voltage was varied in small 5 V increments to 
identify the optimum setting at which the maximum amount of creatinine as well as creatine ions 
remain intact, while the maximum amount of dimer ions [2M+H]+ and [2M+Na]+, is fragmented into 
monomer ions [M+H]+. Creatinine solution (10.0 μg/mL in 90:9.9:0.1 (% v/v/v) methanol, water and 
acetic acid) was analyzed at different fragmentation voltages which were increased in 5 V 
increments from 70 V to a final value of 120 V. A significant decrease in the dimer species, [2M+H]+ 
and [2M+Na]+, was observed as shown in Figure 3.5. 
 
 
Figure 3.5. Mass spectrum of creatinine. (a) Creatinine; (b) creatinine dimer. The reduction in the 
[2M+H]+ and [2M+Na]+ species observed when fragmentation voltage was set at 95 V. 
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A comprehensive picture of what happens to each of the four creatinine ions [M+H]+, [M+Na]+, 
[2M+H]+ and [2M+Na]+ and those of creatine [M+H]+ is reflected in the plot of fragmentation voltage 
against signal intensity (Figure 3.6).  
 
 
Figure 3.6. Change in signal intensity of urinary metabolites with increase in fragmentation voltage.  
(A) Creatine, 132 m/z ( ); (B) Creatinine, 114 m/z ( ); (C) Creatinine sodium adduct, 136 m/z 
( ); (D) Creatinine dimer, 227 m/z ( ); and (E) Creatinine dimer sodium adduct, 249 m/z 
( ). A and B are plotted on the left y-axis and a quadratic regression of both resulted in R2 values 
of 0.997 and 0.977 respectively. C, D and E are plotted on the right y-axis. A quadratic regression of C 
resulted in a R2 value of 0.932. Inverse first order regression of D and E resulted in R2 values of 0.970 
and 0.987 respectively. All data points represent averages of duplicate values. 
 
The hydrogen bonds between the creatinine monomers that form the creatinine dimer species, 
[2M+H]+ and [2M+Na]+, are broken by the fragmentation voltage. An increase in creatinine and 
creatine ions was clearly seen when fragmentation voltage was increased from 70 V to about 90 V. 
However, further increase to greater than 95 V appeared to destroy the monomers. The optimum 
fragmentation voltage was identified as 95 V where a substantial decrease in the dimer species was 
obtained without significant loss in monomer species. 
3.4 The carrier solvent 
The development of a direct infusion mass spectrometry method suited to quantify the urinary 
metabolites required the selection of appropriate solvents. The solvents influence the ability of the 
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analyte to enter the nebulizer capillary and the ESI mechanism. The latter has an effect on the ion 
transportation, ion separation and ion detection [104] which was discussed in detail in subsection 
1.5.1. 
 
The inlet where the sample is introduced into the capillary of the nebulizer posed certain challenges. 
The sample introduction depended solely on the gravitational force on the analyte as a pump was 
not used. The viscosity of the sample determines if the sample will be able to enter the capillary of 
the nebulizer. A solvent containing methanol, water and acetic acid was used in various ratios. All 
the solvent solutions contained 90% methanol and either 9.9% and 0.1% water and acetic acid, 
respectively, or 7.5% and 2.5% water and acetic acid, respectively. The methanol ensured a low 
viscosity and the addition of acetic acid was discussed in section 3.2. 
 
As mentioned, ESI is influenced by the composition of the solvent. Positive ion ESI is usually 
performed with protonated solutions such as methanol/water. The solvent reacts with a weak acid, 
in this case acetic acid, which results in the charge being carried by protonated solvent clusters. 
Protonation of the analyte is facilitated by the low pH of the acidic solution [104]. 
3.5 The primary standard 
The need for a reference compound as a primary internal standard was discussed in section Error! 
Reference source not found.. Two compounds were identified and investigated as possible 
candidates for this purpose. It has been reported in the literature that both 2-phenylbutyric acid 
(PBA)  [107] and 1-methyl-3-phenylpropyl-amine (MPPA) [108-111] are suitable internal standards 
when analyzing urine or other humic samples with analytical methods such as HPLC and GC–MS, 
although both have not specifically been reported as reliable internal standards when analyzing 
urine samples with direct infusion mass spectrometry. 
 
3.5.1 2-Phenylbutyric acid 
 
The PBA was easier to use because it is available as a powder (Scheme 3.2). It has a molecular weight 
of 164.2 g/mol. The PBA met most of the criteria for an internal standard, namely it is not present in 
urine, it does not react with anything in the sample matrix, and both the analyte and PBA are 
affected in the same manner and leads to similar changes in the instrument response. Furthermore, 
the analyte and internal standard produce separate signals, which do not overlap each other or the 
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signals due to matrix components. However, mass spectrometry analysis showed that PBA is not 
readily protonated and prefer to undergo deprotonation of its acidic moiety. PBA could be analyzed 
in the negative mode with a mass spectrometer, but a more suitable internal reference that could be 
readily protonated and analyzed in the positive mode was preferred. The second compound, MPPA, 
was therefore investigated. 
 
 
Scheme 3.2. Chemical structure for PBA. PBA is not easily protonated. 
 
3.5.2 1-Methyl-3-phenylpropylamine 
 
The MPPA is only available as a liquid (Scheme 3.3). The structure of MPPA was considered and the 
protonation of the amine group is possible. It met all the requirements for an internal standard as 
described in the previous subsection.  
 
 
Scheme 3.3. Chemical structure for MPPA. The amine group allows easy protonation which makes 
MPPA better suited as a primary internal standard in positive mode MS analysis. 
 
MPPA has a molecular weight of 149.23 g/mol and is thus comparable to all the urine metabolites of 
interest, namely creatinine, creatine and caffeine. Mass spectrometry analysis of MPPA confirmed 
that it is protonated and thus suitable to act as a primary internal standard. 
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3.6 Calibration curves 
Initially, a study was conducted to establish if creatinine can be employed as a secondary internal 
standard. Creatine was the analyte in unknown quantities. Standards of creatine were prepared and 
5 μg/mL of the internal standard was added to each of the standards. The standards covered a range 
of concentrations similar to that expected to be found in urine to construct a calibration curve for 
creatine. Determination of the resulting response signals allowed for a calibration curve of creatine 
to be obtained over a final concentration range of 1–10 μg/mL (Figure 3.7). The result indicated a 
linear calibration curve for creatine which was expected since the internal standard method corrects 
for any instrumental response factors.  
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Figure 3.7. Calibration curve of creatine. Linear regression of the plot resulted in a R2 value of 0.997. 
All data points represent the mean of duplicate values, with the error bars denoting the standard 
deviation. 
 
The results from this experiment suggested that the quantification of urine metabolites by direct 
infusion mass spectrometry is possible. Standards of creatinine and caffeine were prepared and 5 
μg/mL of the primary internal standard, MPPA, and the secondary internal standard, creatinine, 
were added to the respective sets of standards. The standards covered a range of concentrations 
similar to that expected to be found in urine, taking into account the dilution that occurs during 
sample preparation, to construct a calibration curve for creatinine and caffeine. Determination of 
the resulting response signals allowed for calibration curves of both metabolites to be obtained over 
a final concentration range of 1–10 μg/mL (Figure 3.8). The results indicated linear calibration curves 
for creatinine and caffeine.  
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Figure 3.8. Calibration curves of the urinary metabolites. (A) Creatinine calibration curve; (B) Caffeine 
calibration curve. Linear regression of A and B resulted in R2 values of 0.985 and 0.977 respectively. 
All data points represent the mean of triplicate values, with the error bars denoting the standard 
deviation. 
3.7 Limits of detection and quantification 
The ability of the developed method to accurately detect and quantify the urine metabolites in 
artificial samples was subsequently assessed in terms of the limit of detection (LOD) and limit of 
quantification (LOQ). The LOD of a specific analyte is defined as the lowest concentration of the 
analyte that can be detected that is statistically different from an analytical blank. The definition of 
LOQ is the lowest concentration of a specific analyte which can be quantitatively analyzed with 
reasonable reliability. LOD and LOQ are calculated by estimating the LOD from previous experience 
with the method. A sample containing approximately the same concentration (1 μg/mL) as the LOD 
is prepared and the signal measured for six replicate samples ( 6n ). The standard deviation ( ds ) 
of the six measurements is computed by using the following equation, 
 
1
)( 2




n
xx
s i
i
d    Eq. 3 
 
where n  is the number of measurements, ix  is the value of each measurement and x  is the mean 
of n  measurements.   
 
A B 
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The signal from six blanks (containing no analyte) is measured and the mean value, blanky , calculated. 
By using equation 4 to determine the signal detection limit ( dly ), this procedure produces a dly  
with a 99% chance of being greater than the blank. Once the dly  and signal quantification limit 
( qly ) are known, the LOD and LOQ can be calculated and expressed in concentration units. 
 
dblankdl syy 3
  
Eq. 4 
x
y
mLgLOD dl)/(
  
Eq. 5 
 
dblankql syy 10
  
Eq. 6 
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mLgLOQ
ql
)/(
  
Eq. 7 
 
The LOD and LOQ values for all the urinary metabolites of interest were calculated in this manner 
and the results are shown in Table 3.1. 
 
Table 3.1. LOD and LOQ values for the urinary metabolites of interest. 
Compound ds  blanky  dly  qly  x  
LOD 
μg/mL 
LOQ 
μg/mL 
Analysis 
range 
μg/mL 
Creatine 326.6 1369 2349 4635 32239 0.073 0.144 1 – 10 
Creatinine 1160 438.7 3917 12034 6559 0.597 1.835 1 – 10 
Caffeine 141.9 61.2 486.8 1480 341.0 1.427 4.339 1 – 10 
 
LOD and LOQ are very strict measurements of accuracy and an analytical method that gives very low 
variability in the obtained values is expected to produce satisfactory values.  
3.8 Quantification of artificial samples 
The ability of the developed method to accurately detect and quantify the creatinine and caffeine as 
the urinary metabolites was evaluated. The primary internal standard, MPPA, was added to three 
artificial samples containing an unknown amount of creatinine and analyzed. The concentration of 
creatinine and the percentage recovery were successfully calculated for each sample using the LLS 
equation of the creatinine calibration curve in Figure 3.8. Creatinine as secondary internal standard 
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was used to successfully calculate the concentration and the percentage recovery of caffeine for 
each sample using the LLS equation of the caffeine calibration curve in Figure 3.8. The results are 
reported in Table 3.2. 
 
Table 3.2. Quantitative results for creatinine and caffeine samples with unknown amounts. All the 
data represent the mean of triplicate values, with the standard deviation noted.  
Compound Sample 
Theoretical 
concentration 
μg/mL 
Measured 
concentration 
μg/mL 
% recovery 
Creatinine 
Unknown 1 67.5 68.4±3.1 101±3.6 
Unknown 2 22.5 22.4±0.9 99.6±7.1 
Unknown 3 15.0 15.3±2.3 102±3.8 
Caffeine 
Unknown 1 85.0 82.5±1.4 97.1±2.1 
Unknown 2 12.5 12.3±1.1 98.4±4.7 
Unknown 3 60.0 60.5±0.8 101±5.1 
 
3.9 Quantification of urine sample 
A urine sample was analyzed using the DI–ESI–MS method to detect and quantify creatinine and 
caffeine. The internal standard, MPPA, was added and a final dilution of 100-fold obtained. The 
resulting mass spectrum of the analyzed urine sample is shown in Figure 3.9.  
 
 
Figure 3.9. Mass spectrum of a urine sample diluted 100-fold. Creatinine (a), MPPA (b) and the 
sodium-adduct of (a) are observed at m/z of 114, 150 and 136, respectively. Caffeine is not observed 
at 195 m/z. 
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The mass spectra confirmed the presence of creatinine and MPPA at m/z of 114 and 150, 
respectively. The creatinine sodium adduct was also present at 136 m/z. Creatinine was quantified 
and a concentration of 835±3.1 μg/mL was obtained. The signal for caffeine (195 m/z) was very low 
and many ions due to the urine matrix are observed. The need to dilute urine 100-fold to analyze 
creatinine in the calibration range proved to be detrimental to the determination of caffeine due to 
the low concentration present in the sample. Ionizability of caffeine is a problem even in other 
systems that use it as a calibrant. Analysis of an undiluted urine sample to confirm the presence of 
caffeine was unsuccessful due to the high salt and protein concentrations present which clogged the 
spray capillary rendering ESI impossible. Therefore we were unable to perform simultaneous 
quantification for both compounds in a urine sample. 
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Chapter 4:  
Method validation – Comparison with HPLC-based 
quantitation of creatinine and caffeine 
 
4.1 Introduction 
High performance liquid chromatography (HPLC) is a popular and relatively simple and sensitive 
analytical method commonly used to analyze various substances. It is a fast, reproducible and robust 
form of liquid chromatography which often is highly automated.  HPLC in conjunction with a range of 
detectors has become one of the main tools of a modern laboratory.  
 
However, in contrast to gas chromatography (GC), which was successfully hyphenated with mass 
spectrometry (MS) in the early 1960s and has for long been the golden standard in analytical 
toxicology, the hyphenation of liquid chromatography (LC) with MS took more than 30 years longer 
[112, 113]. At first the scientific and/or practical progress of hyphenating LC with MS was strained by 
using existing LC–UV or GC–MS procedures which had many limitations for this new technique, 
including poor spectral information (in single-stage apparatus), poor ionization reproducibility, and 
susceptibility to matrix effects (ion suppression or enhancements). These limitations of LC–MS have 
in recent years experienced considerable improvements including instrumental advances, the 
development of suitable specimen clean-up procedures to avoid matrix effects, improvements of 
reagents and in chromatographic separation, as well as effective internal standard quantification 
[61].  
 
Electrospray ionization (ESI) was discussed in subsection 1.5.1 and is the ionization method most 
widely employed in LC–MS. In ESI, direct analysis of analyte solutions is made possible by ionization 
at atmospheric pressure. HPLC and MS do, however, present some problems that arise from their 
intrinsically different operative conditions. LC employs (often non-volatile) mobile phases to achieve 
high chromatographic resolution and mass spectrometers generally exhibit a low tolerance for the 
high liquid flows used in LC. Further complications in LC–MS operation stems from the differences 
among classes of analytes with regard to molecular weight, polarity and stability; the variable 
solvent composition of the mobile phase reflecting on the formation of droplets of different 
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dimension and lifetimes; and the compatibility of the chromatographic eluate flow with the sprayer 
operative flow [114]. 
 
Despite these constraints, LC–MS is nowadays becoming a routine technique ideally suited most 
notably for quantification of polar, thermolabile, or low-dosed drugs due to its ability to guarantee 
the stability of analytes in the biosample during the whole analytical procedure [60, 61, 114, 115]. 
However, it is important to bear in mind several aspects when establishing LC–MS screening 
procedures in routine work. The spectral information attainable by electron impact mass spectra in 
GC–MS can be reached in LC–MS only by using product ion spectrum mode on tandem MS 
instruments, whereas the information of single-stage ESI and/or atmospheric pressure chemical 
ionization (APCI) spectra is rather poor. In-source fragmentation caused by increasing the 
fragmentor voltage in ESI and/or APCI allows the formation of structure-related fragments. Traces 
with different fragmentor voltages can be recorded during LC separation using modern apparatus 
which allow very fast switching between voltages. The loss of spectral information can thus be 
limited when analyzing compounds with different fragmentation properties in one run [116-118]. A 
second important consideration is the fact that LC–MS is susceptible to matrix effects, with the 
ionization source determining the extent thereof. APCI is less susceptible to matrix effects than ESI, 
although the sensitivity is generally lower, depending on the analyte, matrix and the instrument 
used and should always be evaluated [119]. In comparison, LC–MS is much more selective and 
sensitive than LC–UV, although the latter should be free of matrix interferences. 
 
The importance of LC–MS in routine quantitative clinical and toxicological analysis of various 
analytes has increased in the past 15 years and has certainly left the development stage, especially 
considering single-stage or tandem LC–MS/MS with ESI or APCI [60, 120]. These LC–MS techniques 
have made it possible to explore new ways to interpret clinical and toxicological data. A few 
examples include the determination of chronic alcohol consumption by determining ethanol 
conjugates in urine, plasma and hair [121], and sensitive detection of chemical agents in hair in the 
case of drug-facilitated crimes [122]. 
 
Several HPLC methods have been described for the analysis of urinary creatinine either alone or in 
conjunction with various other target analytes. These HPLC methods include the use of reversed-
phase LC on a range of different stationary phases, ion-pair chromatography, automatic analyzers 
using cation-exchange columns and more recently hydrophilic interaction chromatography (HILIC) as 
reviewed in section 1.4 [20, 30, 48, 123].  
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Reversed-phase HPLC is a powerful separation technique; however the low retention and poor 
separation of polar molecules are major limitations [123, 124]. Most hydrophilic compounds elute at 
or near the column void volume under typical reversed-phase conditions using conventional C18 
columns and highly aqueous mobile phases [125]. Traditionally, some polar compounds have been 
separated with non-aqueous mobile phases using normal-phase liquid chromatography (NP–LC). A 
difficulty does arise in dissolving hydrophilic compounds in these phases, resulting in an important 
limitation [123]. 
 
HILIC presents a viable alternative to reversed-phase, ion-exchange and normal-phase LC for the 
separation of such polar compounds with the most important reasons being the clear advantages 
with regard to the solubility of biological compounds and no need for compound derivatization. 
These advantages facilitate easier sample processing and compatibility with further mass 
spectrometric analysis, where volatile buffers are used and a low amount of volatile salt is allowed 
[123]. 
 
HILIC is similar to normal-phase chromatography because polar compounds are retained longer than 
the non-polar ones and the polar component of the mobile phase (usually water) is the strong 
solvent. Retention of the polar compounds is achieved by the use of a polar stationary phase in HILIC 
and an initial mobile phase consisting of a high content of an organic solvent. Water in the mobile 
phase forms a stagnant enriched aqueous layer on the polar stationary phase surface. Analytes may 
selectively partition into this layer as described by Alpert [126], and more recently evaluated and 
confirmed by McCalley and Neue [127]. This allows for the promotion of hydrophilic interactions 
between the analyte and the polar hydrophilic stationary phase. The nature of the mobile phases 
used in HILIC is comparable to reversed-phase separations, which results in HILIC being superior to 
normal-phase chromatography with regard to the solubility of analytes in the mobile phase and 
matrix compatibility [123, 128]. 
4.2 Strategy 
The aim of this part of the study was to develop a LC–UV–MS method for the validation of the 
developed DI–ESI–MS method reported in the two previous chapters. Separation with LC should 
reduce matrix effects that could affect the results obtained with the DI–ESI–MS method. A 
comparison between the DI–ESI–MS method and the LC method with either UV or MS detection is 
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therefore needed to determine if significant differences are obtained in terms of a) precision, and b) 
the mean values produced by these methods for validation purposes. Separation with LC should 
reduce matrix effects that can affect the results obtained with the DI–ESI–MS method. The 
structures of creatinine and caffeine were considered in the development of a LC–UV–MS method 
for the separation, detection and quantification of these metabolites. The aspects that were 
considered are discussed in detail below. 
 
4.2.1 Development of LC–UV–MS method 
 
Inspection of the chemical structures and properties of the two metabolites, creatinine and caffeine, 
and the internal standard, MPPA, highlights the parameters that must be considered in the 
development of a suitable HPLC separation method. 
 
The variable number of polar covalent bonds among the two metabolites and the internal standard 
accounts for the most important determinant of differential polarity and hydrophobicity between 
them. These differences in polarity and hydrophobicity can be quantified by calculation of the 
specific partition constant (P) for each compound [129]. Although commonly used for this purpose, 
the log of the calculated octanol/water partition constant, c log P, is only valid for neutral 
compounds. Evaluation of the pKa values of the target molecules reveals that, at a pH of 4.5, all three 
the compounds are to some extent charged due to their respective basic or acidic functional groups. 
The distribution of these compounds in octanol/water mixture therefore becomes pH-dependent. 
The distribution coefficient, D, serves as a quantitative descriptor of hydrophobicity for ionizable 
compounds. Calculation of D depends on the assumption that only the neutral form of a compound 
will partition into the organic phase [130, 131]. The log of D can be calculated from c log P and pKa 
values according to equation 8, 
 
)101log(loglog
)(  apKpHPcD   Eq. 8 
 
where Δ is equal to 1 for acids and -1 for bases. 
 
Ionization of the compounds decreases their retention in reversed-phase chromatography, whereas 
it increases their retention when using HILIC. The pKa, c log P and log D values are presented in Table 
4.1 for the two metabolites and the internal standard under consideration. Hydrophobicity is directly 
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proportional to c log P and log D values, i.e. the larger the c log P and log D value, the more 
hydrophobic the compound. 
 
Table 4.1. Physical properties of two metabolites and internal standard. 
Physical 
property 
Compound 
Creatinine Caffeine MPPA 
pKa
a  4.8 10.4 9.79 
c log Pb -1.76 -0.07 2.12 
log Dc -2.75; -2.45 -0.63 -0.84 
a
 pKa values were obtained from the PHYSPROP©Database, S.R.C. 
b
 log P values were obtained from ChemDraw and calculated using the embedded CLOGP function 
developed by the BioByte Corporation.  
c
 log D values were obtained from SciFinder and calculated using Advanced Chemistry Development 
(ACD/Labs) Software Solaris V11.02 (© 1994-2012 ACD/Labs) at pH 4 (first value) and pH 5 (second 
value). If the log D values are the same value at both pH values, it is reported only once. 
 
The c log P and log D values of the two metabolites and the internal standard exhibit good variation, 
indicating that their separation by reversed-phase LC and/or HILIC, in which the compounds would 
elute either in order of increasing or decreasing hydrophobicity respectively, should be possible. This 
suggests both reversed-phase LC and HILIC as effective methods for the separation of the two 
metabolites and the internal standard. 
 
Two types of detectors, UV and MS, were selected for the development of the HPLC method. UV is 
an established method for the routine quantification of compounds, provided that sufficient 
selectivity and sensitivity is attainable. MS detection on the other hand is most commonly used as a 
qualitative method for identification of compounds of interest. The same optimized experimental 
conditions as reported for the DI–ESI–MS method were used for LC–MS detection. LC–MS also 
allows the generation of extracted ion chromatograms, which were evaluated for quantitative 
analysis in this work. 
 
4.2.2 Metabolite quantification 
 
The quantification of the two metabolites from chromatographic peak areas can be achieved by 
following different approaches. Three common methods of quantification, namely the external 
standard, standard addition and the internal standard method can be used in HPLC for validation of 
the direct infusion mass spectrometry method. The internal standard method was selected for 
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validation by HPLC because this approach was used in the development of the direct infusion mass 
spectrometry method and because the HPLC instrument used was equipped with a manual injector. 
4.3 Materials and experimental procedures 
4.3.1 Chemicals and reagents 
 
All chemical and chromatographic reagents used were of HPLC grade. Creatinine, caffeine, MPPA, 
methanol (MeOH), ammonium acetate, ammonium formate, acetic acid and formic acid were 
purchased from Sigma-Aldrich (St. Louis, Missouri, USA). Acetonitrile (ACN) was purchased from 
ROMIL Pure Chemistry (Cambridge, UK). Millipore water (Millipore, Milford, Massachusetts, USA) 
was used in the preparation of all solutions. 
 
4.3.2 Materials and instrumentation 
 
Standards were used to develop the method. Separations were performed in a HPLC Agilent 1220 
Infinity LC system (Agilent Technologies, Inc., Santa Clara, California, USA) equipped with a gradient 
pump (Model # G4281B) with an integrated degassing unit, and a manual injector. Ultraviolet 
detection was performed using a Model # G4284B variable wavelength detector, which was used in 
the range of 205–260 nm. Chromatograms were recorded and processed using Agilent ChemStation 
software for LC, Rev. B.04.03. The ZORBAX® SB-C18 (2.1  50 mm, 1.8 μm) reversed-phase column 
was obtained from Agilent Technologies and the BETASIL® Diol-100 (4.6  250 mm, 5 μm) HILIC 
column was obtained from Thermo Electron Corporation (Waltham, Massachusetts, USA). The 
BETASIL® Diol-100 column was protected by an aminopropyl SecurityGuard™ (3  4 mm, 5 μm) 
column obtained from Phenomenex, Inc. (Torrance, California, USA). 
 
pKa values were obtained from the PHYSPROP©Database, S.R.C. (North Syracuse, New York, USA). 
Calculation of c log P values for all compounds was performed in ChemDraw® (CambridgeSoft, 
Cambridge, Massachusetts, USA) using the embedded CLOGP function. CLOGP software calculates c 
log P values based on fragmental contributions and was developed by the BioByte Corporation 
(Claremont, California, USA). log D values were obtained from SciFinder and calculated using 
Advanced Chemistry Development (ACD/Labs) Software Solaris V11.02 (© 1994-2012 ACD/Labs). All 
graphical and statistical analyses were performed with SigmaPlot® 11.0 (Systat Software, Inc., 
Chicago, Illinois, USA).  
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4.3.3 Procedures for LC–UV–MS method development 
 
4.3.3.1 Experimental conditions for the reversed-phase column 
 
The ZORBAX® SB-C18 column was evaluated for separation of creatinine, caffeine and MPPA 
standards. A binary solvent system was used that consisted of 5 mM ammonium acetate (pH 4.5) in 
water and ACN in a 99:1 (% v/v) ratio. A 30 min isocratic analysis with a flow rate of 0.250 mL/min 
was used to analyze a 2 μL sample injection containing 10 μg/mL creatinine, caffeine and MPPA 
dissolved in 90:7.5:2.5 (% v/v/v) methanol, water and acetic acid. Detection was performed at 250 
nm. The analysis was repeated at a flow rate of 1.000 mL/min in a second experiment, which was 
also repeated with detection performed at 230 nm.  
 
4.3.3.2 Experimental conditions for the HILIC column 
 
The BETASIL® Diol-100 column was evaluated and used for the development of an extended method 
for the separation of creatinine, caffeine and MPPA standards. A binary solvent system was used 
that consisted of 5 mM ammonium acetate (pH 4.5) in water and ACN, respectively. Initially a 12 min 
analysis method (Method A) with a flow rate of 1.000 mL/min was used to analyze a 2 μL sample 
injection containing 10 μg/mL creatinine, caffeine and MPPA dissolved in pure water. The method 
started with 99% ACN and 1% ammonium acetate, after which the percentage of ammonium acetate 
was increased over time as follows: isocratic, 0-2 min; 1-50% ammonium acetate, 2-10 min; isocratic, 
10-11 min; 50-1% ammonium acetate, 11-12 min. A 5 min post-run ensured the system was at initial 
conditions. Detection was performed at 210 nm.  
 
A second gradient profile was evaluated by injecting 2 μL of a sample containing 100 μg/mL 
creatinine, caffeine and MPPA dissolved in pure water. The analysis method (Method B) was 
extended to 28 min with a flow rate of 0.500 mL/min and started with 99% ACN and 1% ammonium 
acetate, after which the percentage of ammonium acetate was increased over time as follows: 
isocratic, 0-2 min; 1-50% ammonium acetate, 2-20 min; isocratic, 20-25 min; 50-1% ammonium 
acetate, 25-27 min; isocratic, 27-28 min. A 5 min post-run ensured the system was at initial 
conditions. Absorbance was measured at 214 nm. 
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4.3.3.3 Modified methods for the separation of metabolites 
 
Chromatographic conditions were the same as for establishing metabolite Rt-values (subsection 
4.3.3.2). These conditions were kept constant with respect to the column, injection volume, 
absorbance detection wavelength and post-run time. Adjustments were only made to the solvent 
system, analysis time and gradient profiles for the various modified methods with respect to Method 
B as described in the previous subsection. 
 
Method C 
The binary solvent system of the analysis method was changed to consist of 10 mM ammonium 
formate (pH 4.48) in water and ACN, respectively. The same gradient profile as Method B was used. 
 
Method D 
The binary solvent system of the analysis method was changed to consist of 0.05 % (v/v) formic acid 
(pH 4.5) in water and ACN, respectively. The same gradient profile as Method B and C was used. 
 
Method E 
The analysis time of the method was adjusted to 24 min and gradient profile changed to start with 
99% ACN and 1% formic acid, after which the percentage of formic acid was increased over time as 
follows: isocratic, 0-2 min; 1-55% formic acid, 2-20 min; isocratic, 20-22 min; 55-1% formic acid, 22-
23 min; isocratic, 23-24 min. The rest of the conditions remained unchanged with respect to Method 
D. 
 
4.3.4 Procedures for establishing calibration curves 
 
Stock solutions containing 1 mg/mL standard were prepared for creatinine, caffeine and MPPA in 
distilled water. Dilutions of each standard stock were made with distilled water. Two detectors were 
used, namely the variable wavelength detector (VWD) and the mass spectrometer detector (MSD) 
resulting in four sets of calibration curves: a calibration curve each for creatinine and caffeine with 
the different detectors. The sets contained either creatinine or caffeine as the analyte and MPPA as 
internal standard in each case. The standard mixtures were prepared in triplicate to contain 5, 10, 
25, 50, 75 and 100 μg/mL of metabolite and 50 μg/mL of the internal standard for analysis of 
samples in the same concentration range. 
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Each set of standards was analyzed in triplicate by LC–UV–MS with Method E and blank runs were 
performed after every sample run to ensure that there was no carry-over between runs. The peak 
areas of interest were obtained by manual integration and calibration curves of peak area versus 
concentration were constructed for both the LC–UV and MS extracted ion chromatograms. The MS 
extracted ion chromatograms were obtained for ions at m/z of 114, 150 and 195 for creatinine, 
MPPA and caffeine, respectively. Calibration curve sets were fitted with linear equations over the 
concentration range of 5–100 μg/mL by linear regression in SigmaPlot® 11.0. 
 
  Eq. 9 
 
4.3.5 Preparation of unknown and urine sample 
 
The three samples with unknown amounts of creatinine and caffeine were prepared independently 
by a laboratory at the Department of Biochemistry, Stellenbosch University (Stellenbosch, South 
Africa). Urine from a subject was collected over 24 hours. After each collection, the urine was 
immediately stored at 4°C. After 24 hours the collections were pooled and a sample was taken. 
Before analysis, the unknown and urine samples were kept at room temperature for 30 min and 1 
mL was then diluted two times using a stock solution of 100 μg/mL of the internal standard, MPPA, 
in distilled water. The samples were then ready for LC–UV–MS analysis. 
4.4 Results and discussion 
4.4.1 Detection of metabolites by UV 
 
Detection of creatinine, caffeine and MPPA by UV was evaluated to establish the optimum 
wavelength at which all three analytes absorb. Detection at 210, 214, 220, 230, 250 and 254 nm 
were considered with absorbance at 214 nm determined as optimum for all three analytes. 
 
4.4.2 Separation of metabolites by HPLC 
 
The development of an LC–UV–MS method required that appropriate stationary and mobile phases 
be selected. Thereafter, the next challenge was to optimize the solvent gradient for efficient 
separation of both metabolites in such a manner that baseline resolution and symmetric peak 
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shapes could be achieved. Only after both these objectives were achieved could the LC–UV–MS 
method be deemed suitable for quantitative studies. The details of the method development are 
discussed in the following subsections. 
 
4.4.2.1 Reversed-phase HPLC method 
 
We decided to investigate the use of a hydrophobic stationary phase based on the motivation 
provided in subsection 4.2.1, and to combine it with a polar mobile phase. A ZORBAX® SB-C18 was 
evaluated for separation of creatinine, caffeine and MPPA. 
 
The ZORBAX® SB-C18 column contains sterically-protected hydrophobic C18 chains chemically 
bonded to high purity ZORBAX® porous silica microspheres. The column is especially suited in 
applications that utilize high-sensitivity detectors that require low backgrounds, e.g., mass 
spectrometers. The column was evaluated using a binary solvent system consisting of ammonium 
acetate and ACN to elute the analytes from the column. The predicted elution order of the analytes 
(creatinine → caffeine → MPPA) could not be confirmed due to creatinine and caffeine being the 
only metabolites to elute from the column using the isocratic method. The internal standard, MPPA, 
was strongly retained on the column and could only be eluted with a gradient-based method 
containing more than 75% ACN. Sufficient retention of creatinine could not be achieved with an 
isocratic or gradient-based solvent system, therefore this method was not explored further. 
 
4.4.2.2 HILIC-based separation method 
 
The BETASIL® Diol-100 column was evaluated using a mobile phase consisting of ammonium acetate 
and ACN. An isocratic-based solvent system proved to be insufficient to confirm the predicted 
elution order of the analytes in HILIC (MPPA → caffeine → creatinine) since both creatinine and 
MPPA did not elute from the column under these conditions. A gradient elution system (Method A) 
was found to give sufficient separation of the analytes to allow for development of an HPLC-based 
method. 
 
The Rt of the analytes was determined from the resulting HPLC chromatogram and are 5.428, 8.748 
and 9.362 min, respectively. These values did not confirm the elution order, namely MPPA → 
caffeine → creatinine, predicted by the c log P values. This is most likely due to the fact that 
creatinine and MPPA are in a charged state under the mobile phase conditions and the c log P values 
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are only applicable to neutral compounds. log D values calculated based on the pKa values of the 
analytes predict the elution order to be caffeine → MPPA → creatinine, which is indeed observed, 
although the elution of MPPA was expected to be closer to caffeine than to creatinine. 
 
Subsequent HPLC analyses of different analyte concentrations revealed elevated background 
interferences. The detection wavelength was adjusted to 214 nm in an attempt to lower the 
background absorption. Furthermore, the analysis time increased (Figure 4.1) and the flow rate 
halved to operate closer to the optimal flow rate in HILIC. Although some of the initial background 
absorption was found to decrease (Figure 4.2.), this could present a problem for future application 
of the method to separate and quantify urinary metabolites.  
 
Figure 4.1. Gradient profile (Method B) used for the elution of creatinine, caffeine and MPPA. 
Modifications were made to analysis time (extended from 12 to 28 min), flow rate (changed from 
1.000 to 0.500 mL/min) and detection wavelength (changed from 210 to 214 nm) compared to 
Method A. 
 
 
Figure 4.2. Analysis of 100 μg/mL creatinine, caffeine and MPPA by HILIC using Method B with 
detection at 214 nm. The retention times of creatinine, caffeine and MPPA are 16.452, 11.478 and 
14.997 min respectively. 
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Ammonium acetate and ammonium formate both absorb at 214 nm [123] which was observed in 
the current method for the former. The solvent system was therefore deemed unsuited for further 
investigation and needed to be modified because of the presence of high background absorption. 
 
4.4.2.3 Modified gradient-based separation methods 
 
In the first prominent modification (Method C, Figure 4.3), the solvent system was changed to 10 
mM ammonium formate and ACN to compare the background absorption to that of the previous 
solvent system. All the other conditions remained unchanged. A reduction in the number of blank 
peaks was observed, with only the peaks of the analytes present (Figure 4.4). Caffeine eluted as a 
relatively broad peak and the separation of creatinine and MPPA was not adequate. Subsequent 
modifications of Method C included a combination of extended analysis time and modified gradient 
profiles which proved insufficient in resolving these issues.  
 
Figure 4.3. Gradient profile for Method C used for the separation of creatinine, caffeine and MPPA. 
The solvent system was modified to consist of ammonium formate and ACN. 
 
 
Figure 4.4. Analysis of 100 μg/mL creatinine, caffeine and MPPA with ammonium formate/ACN. The 
retention times of creatinine, caffeine and MPPA are 19.600, 11.728 and 19.020 min respectively. 
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In the second prominent modification (Method D), the solvent system was changed to 0.05 % (v/v) 
formic acid in water and ACN to compare the resulting resolution and peak shapes to those of the 
previous solvent system. All the other conditions were the same as for Method C. The peak shape of 
caffeine was enhanced, although it needed further optimization. The separation of creatinine and 
MPPA was improved, although it was still inadequate.  
 
The third prominent modification (Method E) entailed the optimization of Method D. Subsequent 
analyses with modified gradient profiles revealed that increased separation of the creatinine and 
MPPA peaks could be achieved with a solvent system consisting of 1% of a 0.05% (v/v) formic acid in 
water and 99% ACN at the start, which was varied according to the following gradient: isocratic, 0-2 
min; 1-55% formic acid, 2-20 min; isocratic, 20-25 min; 55-1% formic acid, 25-27 min; isocratic, 27-28 
min (Figure 4.5). The resulting separation is shown in Figure 4.6. 
 
Figure 4.5. Gradient profile of Method E for the separation of creatinine, caffeine and MPPA. The 
solvent system was modified to consist of 0.05% (v/v) formic acid in water and ACN, and the 
gradient profile was adjusted. 
 
 
Figure 4.6. Analysis of 100 μg/mL creatinine, caffeine and MPPA with formic acid/ACN. The retention 
times of creatinine, caffeine and MPPA are 17.938, 11.315 and 16.738 min respectively. 
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Closer inspection of the resulting chromatogram confirms that the separation of the analytes occurs 
within the first 20 min of Method E. The analysis time was changed to 24 min in order to optimize 
the time and decrease the amount of solvent consumed during the analysis (Figure 4.7). This 
simplified and shortened method proved to be the most successful gradient method for the 
separation of the analytes using HILIC. Using this method, analyte standards gave Rt values shown in 
Table 4.2.  
 
 
Figure 4.7. Analysis of 75 μg/mL creatinine, caffeine and MPPA using the optimized HILIC method. 
Chromatogram A: UV detection at 214 nm. Chromatogram B: Overlay of extracted ion 
chromatograms for creatinine (m/z 114), caffeine (m/z 195) and MPPA (m/z 150). The retention 
times of creatinine, caffeine and MPPA are 17.713, 11.213 and 16.428 min respectively. 
 
Table 4.2. Retention times of urinary metabolites and internal standard, MPPA, with gradient-based 
HPLC Method E. 
Standard Rt (min) 
Caffeine 11.213 
MPPA 16.428 
Creatinine 17.713 
 
A 
B 
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4.4.3 Metabolite quantification 
 
The internal standard method was employed for the quantification of the urine metabolites: 
creatinine and caffeine. Quantification was achieved by generating calibration curves for the 
metabolites as described in the following subsection. 
 
4.4.3.1 Calibration curves 
 
Standards of creatinine and caffeine were prepared and 50 μg/mL of the internal standard, MPPA, 
was added to the respective sets of standards. The creatinine standards covered a range of 
concentrations similar to those expected to be found in urine, taking into account a 10-fold dilution 
that occurs during sample preparation. Determination of the resulting response using both UV (214 
nm) and MS (extracted ion chromatogram) signals allowed calibration curves for both metabolites to 
be obtained over a final concentration range of 5–100 μg/mL (Figure 4.8).  
 
The LC–UV calibration curves displayed a linear relationship over the concentration range of 5–100 
μg/mL for both analytes. The LC–MS extracted ion calibration curves displayed a linear relationship 
over the concentration range of 5–25 μg/mL for both analytes, with large discrepancies at higher 
analyte concentrations. From the calibration curves, it is evident that quantification by LC–UV is 
more reliable than using LC–MS. Linearity is affected to a greater extent at higher analyte 
concentrations in MS detection possibly due to space charge effects at these levels. 
 
4.4.3.2 Limits of detection and quantification 
 
The ability of the developed method to accurately detect and quantify the urine metabolites in 
artificial samples was subsequently assessed in terms of the limit of detection (LOD) and limit of 
quantification (LOQ). The LOD of a specific analyte is defined as the lowest concentration of the 
analyte that can be detected that is statistically different from an analytical blank. The definition of 
LOQ is the lowest concentration of a specific analyte which can be quantitatively analyzed with 
reasonable reliability [132]. 
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Figure 4.8. Calibration curves of the urinary metabolites. A and B) Creatinine calibration curves; C 
and D) Caffeine calibration curves. A and C were constructed using UV detection at 214 nm. B and D 
were constructed using MS extracted ion chromatograms (m/z 195 and 114 for caffeine and 
creatinine, respectively). Linear regression of A, B, C and D resulted in R2 values of 0.991, 0.957, 
0.990 and 0.927 respectively. All data points represent the mean of triplicate values, with the error 
bars denoting the standard deviation. 
 
External calibration curves (not shown here) were constructed for the determinations of the LODs 
and LOQs, which are calculated by considering σ, the residual standard deviation of the regression 
line (also known as the standard error of estimate of regression). Calculating σ in this manner gives a 
value that is expressed in the same units as that used for detection, i.e. the same units as the y-axes 
of the calibration curves. By substituting σ for y in the linear calibration equation (y = mx + c), σ can 
also be expressed in terms of concentration. Based on a 95% confidence level, the LOD is normally 
considered to be equal to 3σ and LOQ as equal to 10σ [132], although in this case the LOD and LOQ 
for all the urinary metabolites of interest need to be calculated from the external calibration curves 
using equations 10 and 11 respectively,  
 
A C 
A B B D 
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where 0y  is the y-intercept and m  is the slope of the (external standard) linear calibration 
regression line. The results are shown in Table 4.3. 
 
Table 4.3: LOD and LOQ values for the urinary metabolites of interest obtained using LC–UV–MS 
Method E. 
Compound 
Detection 
method 
σ Slope Intercept R2 
LOD 
μg/mL 
LOQ 
μg/mL 
Analysis 
range 
μg/mL 
Creatinine 
UV 27.753 5.739 29.492 0.983 9.369 43.222 5 – 100 
MS 479103 67135 913082 0.963 7.809 57.764 5 – 100 
Caffeine 
UV 49.742 11.471 8.259 0.986 12.288 42.642 5 – 100 
MS 116031 15219 121037 0.958 14.919 68.286 5 – 100 
 
LOD and LOQ are very strict measurements of accuracy and an analytical method that gives very low 
variability in the obtained values is required to produce satisfactory values. Lower LODs are expected 
for detection of both creatinine and caffeine by MS than by UV. However, the calculated values 
indicate a lower LOD for the detection of only creatinine by MS. This is partially due to the larger 
variability in the MS data for caffeine, especially at higher concentrations, which results in higher 
LOD and LOQ values calculated according to the method described above (even though the 
extracted ion chromatogram signals at these levels show good intensity). The linearity of the 
calibration curves indicate high variability in the standard deviations of caffeine and therefore affect 
the reproducibility of this detection method. Selected ion monitoring (SIM) can potentially address 
this problem, but was not explored in the current study. Furthermore, ionization of caffeine is likely 
not favored under the mobile phase conditions used here.  
 
The LOQ values for both creatinine and caffeine by UV detection are lower compared to the values 
obtained by MS detection. Despite UV being less selective and sensitive at low wavelengths, it is 
better suited for the quantification of the target analytes than MS under the LC conditions used 
here. It is important to point out though that using UV detection, compound identification is based 
solely on Rt‘s of the compounds of interest, which is not very reliable at low wavelengths. MS in scan 
mode on the other hand allows identification of the compounds of interest by their mass spectra. 
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The LC–UV–MS method developed here therefore combines the two detection methods to 
complement one another in order to perform both qualitative (MS) and quantitative (UV) analysis. 
4.5 Quantification of unknown samples 
The ability of the developed method to accurately detect and quantify creatinine and caffeine as 
urinary metabolites was evaluated.  
 
The internal standard, MPPA, was added to three artificial samples, prepared independently, 
containing unknown amounts of creatinine and caffeine, and analyzed using the developed LC–UV–
MS method. The concentrations and recoveries were successfully calculated for different 
concentrations in each sample using the LLS equations of the respective calibration curves in Figure 
4.10. The results are reported in Table 4.4. 
 
Table 4.4. Quantitative results for samples with unknown amounts of creatinine and caffeine. All the 
data represent the mean of triplicate values, with the standard deviation noted. 
Compound Sample 
Theoretical 
concentration 
μg/mL 
LC–UV* LC–MS* 
Measured 
concentration 
μg/mL 
% recovery 
Measured 
concentration 
μg/mL 
% recovery 
Creatinine 
Unknown 1 67.5 66.8±1.7 99.0±2.5 68.4±0.9 101±1.3 
Unknown 2 22.5 22.4±0.4 99.4±1.8 23.8±0.3 106±1.1 
Unknown 3 15.0 15.0±0.2 100±1.0 15.1±0.6 101±3.7 
Caffeine 
Unknown 1 85.0 87.8±1.2 103±1.5 83.5±6.3 98.3±7.4 
Unknown 2 12.5 13.0±0.4 104±3.0 10.7±2.8 85.3±22.6 
Unknown 3 60.0 61.7±1.7 103±2.9 72.1±1.5 120±2.5 
* Using HILIC Method E and the calibration data reported in Figure 4.8. 
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4.6 Comparison of results 
4.6.1 F-test and Student’s t-test 
 
In the comparison of the values obtained from a set of results with either the true value or other 
sets of data, it is possible to determine whether an analytical procedure provides accurate and/or 
precise values, or if one method is superior to another. The two most common methods for 
comparing results are the F-test (the variance ratio test) and the Student’s t-test [132]. 
 
When a new analytical method is being developed it is common practice to compare the values for 
the mean and precision of the new test method with those of an established (reference) procedure. 
In this case the comparison was done between three newly developed analytical methods: DI–ESI–
MS, LC–UV and LC–MS. 
 
The F-test is used to compare the precision of two sets of data obtained from the results of two 
different analytical methods. The F-value calculated from the equation: 
 
2
2
B
A
s
s
F    Eq. 12 
 
where 
As  and Bs  are the standard deviations for data set A and B, respectively. 
 
There must not be a significant difference between the precision of the methods. Hence the F-test is 
applied prior to using the Student’s t-test.  
 
The Student’s t-test is used for small sample numbers and its purpose is to compare the mean from 
a sample with some standard value and to express some level of confidence of the comparison. The 
value of t when comparing two sample means 1x  and 2x  is given by the expression: 
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where 
1n   and 2n  are the number of observations for two samples, respectively, and ps  is the 
pooled standard deviation, calculated from the two sample standard deviations 1s  and 2s , as 
follows: 
 
2
)1()1(
21
2
22
2
11



nn
snsn
s p   Eq. 14 
 
The F-test was employed to compare the precision of the results of the DI–ESI–MS method with the 
LC–UV–MS method using both UV and MS data, and also comparing the UV and MS data with each 
other. The mean values obtained using these three methods for the three samples with unknown 
amounts of creatinine and caffeine were used for this purpose. The value obtained for F was 
checked for its significance against values in the F-table calculated from an F-distribution 
corresponding to the degrees of freedom (n – 1, where n = 3) for the two sets of data. The F-values 
obtained for the three sets of data are tabulated in Table 4.5. 
 
There is no significant difference at the 10 percent probability level between the precisions of five of 
the six sets of results when comparing data for the DI–ESI–MS method with those obtained by LC–
UV; one set of results (creatinine in Unknown 3) clearly showed a significant difference. A 
comparison of the DI–ESI–MS method with the LC–MS method showed no significant difference at 
the 10 percent level for two of the three sets of results for caffeine, with the other set of results 
(caffeine in Unknown 1) showing a significant difference at the 1 percent level. The three sets of 
results for creatinine showed no significant difference at the 5 percent level between the values.  
 
Three of the six sets of results in a comparison between the two methods of detection (UV and MS) 
used in combination with LC separation showed no significant difference at the 10 percent level, and 
one set of results at the 5 percent level. The remaining two sets of results (caffeine in Unknowns 1 
and 2) reveal a significant difference between the two methods. The amount of caffeine in Unknown 
1 and creatinine in Unknown 3 are close to the LODs for the respective compounds. Therefore the 
significant difference in the F-test comparisons for these two samples is expected. 
 
Despite the significant differences between four of the sets of results, data for all three methods can 
be viewed as comparable due to no significant difference at the 5 percent level for most of the 
comparisons between the sets of results. 
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Table 4.5. F-test comparison of precisions of three different analytical methods. For P = 0.10, 0.05 
and 0.01, the F-distribution for two degrees of freedom are 9.00, 19.00 and 99.00, respectively. 
  F-test comparisons 
Compound Sample 
DI–ESI–MS vs. 
LC–UV 
DI–ESI–MS vs. 
LC–MS 
LC–UV vs. 
LC–MS 
Creatinine Unknown 1 3.23a,b 12.49b 3.87a,b 
 Unknown 2 4.84a,b 12.47b 2.58a,b 
 Unknown 3 217.29c 16.35b 13.29b 
Caffeine Unknown 1 1.29a,b 19.69c 25.41c 
 Unknown 2 7.81a,b 7.15a,b 55.84c 
 Unknown 3 5.08a,b 3.72a,b 1.37a,b 
a
 F-value indicates no significant difference between the precision of the two sets of results at the 10 percent level. 
b
 F-value indicates no significant difference between the precision of the two sets of results at the 5 percent level. 
c
 F-value indicates a significant difference between the precision of the two sets of results at the 1 percent level. 
 
The exceptions in all cases are where the analyte of interest is close to the LOD value of a particular 
method. The Student’s t-test can therefore be used with confidence and the values are shown in 
Table 4.6. 
 
Table 4.6. Student’s t-test values for the comparison of the three analytical methods. For P = 0.10, 
0.05 and 0.01, the t-distribution for two degrees of freedom are 2.92, 4.30 and 9.93, respectively. 
  t-test comparisons 
Compound Sample 
DI–ESI–MS vs. 
LC–UV 
DI–ESI–MS vs. 
LC–MS 
LC–UV vs. 
LC–MS 
Creatinine Unknown 1 0.72a 0.02a 1.55a 
 Unknown 2 0.05a 2.12a 4.62c 
 Unknown 3 0.19a 0.12a 0.06a 
Caffeine Unknown 1 3.59b 0.24a 0.99a 
 Unknown 2 0.88a 0.86a 1.14a 
 Unknown 3 2.25a 11.75d 9.43c 
a
 t-value indicates no significant difference between the mean results of the two methods at the 10 percent level. 
b
 t-value indicates no significant difference between the mean results of the two methods at the 5 percent level. 
c
 t-value indicates a significant difference between the mean results of the two methods at the 1 percent level. 
d
 t-value indicates a highly significant difference between the mean results of the two methods below the 1 percent level. 
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There is no significant difference at the 10 percent probability level between the precision of five of 
the six sets of results (and one set of results at the 5 percent level) when comparing the DI–ESI–MS 
method with the LC–UV method. Data for five of the six sets of results obtained by the DI–ESI–MS 
and the LC–MS method showed no significant difference at the 10 percent level and the remaining 
set of results (creatinine in Unknown 3) reveals a significant difference between the two methods. A 
comparison of the LC–UV method with the LC–MS method showed no significant difference at the 
10 percent level for four of the six sets of results with two sets of results (creatinine in Unknown 2 
and caffeine in Unknown 3) having a significant difference at the 1 percent level. 
 
4.6.2 Paired t-test 
 
The paired t-test was also employed to validate the DI–ESI–MS method with the LC–UV and LC–MS 
methods, and the last two methods with each other. The three methods were used for the analysis 
of the three samples with differing unknown amounts of creatinine and caffeine, with the results of 
only the DI–ESI–MS and the LC–UV methods reported in Table 4.7 as an example.  
 
Table 4.7. Calculation of the differences between the results of the DI–ESI–MS and the LC–UV 
methods. The differences between each pair of results ( d ) and the mean of the difference ( d ) is 
obtained. d is subtracted from d  for each pair of results and the square of each value is calculated. 
The sum of all the squares (  2)( dd ) is used in the calculation of the standard deviation in order 
to determine the t-distribution value. 
Compound DI–ESI–MS LC–UV d  dd    
2)( dd   
Creatinine 68.4 66.8 1.5 0.9  0.83 
 22.4 22.4 0.0 -0.6  0.35 
 15.3 15.0 0.3 -0.3  0.10 
  
                  d = 1.9   
2)( dd =  1.28 
                         d = 0.6    
Caffeine 82.5 87.8 -5.3 -2.9  8.54 
 12.3 13.0 -0.7 1.7  2.93 
 60.5 61.7 -1.2 1.2  1.47 
  
                  d = -7.1                       
2)( dd =  12.98 
                         d = -2.4    
 
The differences (d ) between each pair of results are calculated and d , the mean of the difference, 
is obtained. d is subtracted from d  for each pair of results and the square of each value is 
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calculated. The sum of all the squares (  2)( dd ) is used in the calculation as showed in 
equation 15.  The standard deviation ( ds ) of the differences is evaluated and the t-distribution is 
calculated using equations 15 and 16. 
 
1
)( 2




n
dd
sd    Eq. 15 
ds
nd
t    Eq. 16 
 
Data obtained with the DI–ESI–MS and LC–UV methods were also compared with those obtained by 
LC-MS. The calculated t-distribution values of the three method comparisons are reported in Table 
4.8. 
 
Table 4.8. Paired t-test comparison of three different analytical methods. For P = 0.10, 0.05 and 0.01, 
the t-distribution for two degrees of freedom are 2.92, 4.30 and 9.93, respectively. 
Compound 
t-distribution 
DI–ESI–MS vs. 
LC–UV 
DI–ESI–MS vs. 
LC–MS 
LC–UV vs. 
LC–MS 
Creatinine 1.35 0.79 2.13 
Caffeine 1.62 0.91 0.28 
 
There is no significant difference at the 10 percent level between the quantitative data obtained by 
any of the three methods. 
4.7 Quantification of urine sample 
After successfully using the LC–UV–MS method to quantify artificial samples, the method was 
evaluated for the analysis of a urine sample to detect creatinine and caffeine. The internal standard, 
MPPA, was added to a urine sample diluted two-fold and analyzed using Method E to determine the 
sensitivity of the method. The resulting LC–UV and extracted ion chromatogram as well as the mass 
spectra for creatinine, caffeine and MPPA of the analyzed urine sample are shown in Figure 4.9.  
Stellenbosch University  http://scholar.sun.ac.za
 61 
 
 
 
 
 
Figure 4.9. Analysis of a urine sample. A) UV 
chromatogram at 214 nm; B) extracted ion 
chromatograms for each of the analytes; C, D 
and E) mass spectra obtained for caffeine, 
creatinine and MPPA, respectively, in the urine 
sample. The sample was diluted two-fold. 
A 
C 
B 
D 
E 
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The mass spectra for each peak in the extracted ion chromatogram confirmed the presence of the 
respective compounds. The signal for caffeine (195 m/z) was very low and many ions due to the 
mobile phase and matrix are observed as shown in Figure 4.9 C. In mass spectrum D both creatinine 
(114 m/z) and its dimer (227 m/z) are present; with mass spectrum E confirming the presence of 
MPPA (150 m/z). In both the LC–UV and LC–MS analyses, caffeine was close to the LOD rendering its 
quantification impossible. The sample needed to be diluted ten-fold to ensure creatinine was within 
the calibration range, but was not performed since the detection of caffeine would not be possible 
at such a high dilution factor. Therefore we were unable to perform simultaneous quantification for 
both compounds in a urine sample.  
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Chapter 5:  
Conclusion 
 
5.1 Overview of achievements 
The use of creatinine as internal standard presents a valuable tool in clinical and forensic studies. 
This thesis presents an initial study on the detection and quantification of creatinine, creatine and 
caffeine by direct infusion mass spectrometry. The reason for this research is to overcome 
adulteration problems such as the deliberate addition of water to dilute urine samples by using 
creatinine as an endogenous control substance against which concentration levels of metabolite of 
interest can be compared. The study addressed this problem by development of a direct infusion 
mass spectrometry analytical method for detection and quantification of creatinine, creatine and 
caffeine.  
 
In pursuit of this aim, a simple and sensitive analysis method was developed based on a direct 
infusion of the metabolites into a mass spectrometer. Key parameters for the direct infusion were 
established by considering the composition of the analyte solution, ionization of the compounds, 
sample introduction, separation and detection of ions, and the use of a suitable internal standard for 
quantitative purposes. The analyte solution contained methanol, water and acetic acid. Methanol 
ensured low viscosity and volatility of the carrier solvent whilst water was included due to the 
metabolites being highly polar. Acetic acid promoted quantitative ionization in positive ionization 
mode. Sample introduction was performed by continuous infusion of the analyte solution and the 
solution entered the spray needle by gravitational force alone. Solvent pumping was not required. 
This ensured consistent and reproducible flow speed. To ensure the analyte molecules were in 
monomeric form and did not form clusters the fragmentation voltage was set at 95 V. 1-Methyl-3-
phenylpropylamine was selected as internal standard since it met all the requirements to determine 
the concentration of creatinine. Establishment of these conditions rendered the use of the direct 
infusion electrospray ionization mass spectrometry (DI–ESI–MS) method possible. 
 
A positive highlight of the DI–ESI–MS method was the successful construction of calibration curves 
for creatinine, creatine and caffeine with good linearity over a concentration range of 1–10 μg/mL. 
The linear regression of the calibration curves resulted in R2 values of 0.985, 0.997 and 0.977 for 
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creatinine, creatine and caffeine, respectively. Limit of detection (LOD) of 0.597 μg/mL, 0.073 μg/mL 
and 1.427 μg/mL was obtained for creatinine, creatine and caffeine, respectively. Applicability of this 
method was confirmed by successfully quantifying three artificial samples containing unknown 
amounts of compounds of interest with mean recoveries of 99.6–102% for creatinine and 97.1–
101% for caffeine. The DI–ESI–MS method requires minimal sample pretreatment rendering it fast 
and facile with a total analysis time of 5 min. It was found that the calibration curve for caffeine 
could not be used in the application of the method in analysis of a human urine sample due to the 
low concentration of caffeine present compared to the concentration of creatinine. 
 
A liquid chromatography (LC) method with ultraviolet (UV) and mass spectrometry (MS) detection 
was developed using a BETASIL® Diol-100 HILIC column to validate the DI–ESI–MS method. A 
successful elution protocol was developed and optimized for the separation of creatinine, caffeine 
and the internal standard, MPPA. The chromatographic analysis procedure was subsequently 
employed to obtain linear calibration curves over a concentration range of 5–100 μg/mL for 
creatinine and caffeine quantification using the two detectors, UV and MS. The LODs for creatinine 
with UV and MS were 9.369 and 7.809 μg/mL, respectively. Caffeine had LODs of 12.288 μg/mL and 
14.919 μg/mL with UV and MS, respectively. These LODs are significantly higher than those reported 
for the DI–ESI–MS method (in part due to the poor reproducibility of manual injection). The analysis 
of three artificial samples containing unknown amounts of compounds of interest were performed 
with mean recoveries of 99.0–100% for creatinine and 103–104% for caffeine when using LC–UV. 
Analysis using LC–MS resulted in mean recoveries of 101–106% for creatinine and 85.3–120% for 
caffeine. These values are comparable to the percentage recoveries obtained with the DI–ESI–MS 
method. 
 
Statistical analysis, including the F-test, Student’s t-test and paired t-test, of the data obtained by DI–
ESI–MS, LC–UV and LC–MS methods proved that a significant difference between the methods at a 
confidence level of 95% does not exist, except for samples with amounts of compound close to the 
LOD. Therefore the DI–ESI–MS method was successfully validated by the LC–UV–MS method. 
5.2 Future work 
Problems encountered with the simultaneous quantification of creatinine and caffeine in a human 
urine sample by the DI–ESI–MS method that was developed in this work, are due to the low 
amounts of caffeine present rather than the analytical method itself. This is evident from the 
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relatively higher limits of detection for caffeine compared to creatinine and creatine. Construction of 
a calibration curve for creatine and caffeine can prove to be more useful since both compounds are 
present at lower concentrations in urine. Direct infusion mass spectrometry has potential for 
quantitative determinations due to its sensitivity, high selectivity, wide dynamic range, robustness, 
and the ability to identify metabolites. Furthermore it has the greatest potential for high sample 
throughput with minimal or no sample pretreatment. Introduction of samples via paper or fibers 
could be a possibility for direct analysis of samples and to improve electrospray ionization of the 
target molecules for quantitative purposes. Alternative mass analyzers can also be employed to 
greatly contribute to the sensitivity of direct infusion mass spectrometry. DI–ESI–MS can be applied 
in various chemical and biochemical fields, including clinical and forensic toxicology, anti-doping 
tests in sports performance studies, food analysis, and metabonomic and metabolomic studies. 
 
The difficulties encountered with the LC–UV–MS validation method developed in this study can be 
attributed to the conversion of peak areas to metabolite concentrations. The relatively high limits of 
detection could in part be the result of poor injection reproducibility using manual injection. In order 
to accurately convert peak areas to concentrations, more reliable calibration curves will be required. 
In future these calibration curves will be constructed by analysis of standards of which the absolute 
concentrations has been confirmed by an independent method such as the classical Jaffé reaction. 
 
Caffeine was selected as a model compound to represent common drugs or drug metabolites that 
may be analyzed. The analysis of real drugs or drug metabolites can in future performed using this 
DI–ESI–MS method. 
5.3 Final remarks 
The results presented in this work represent the successful development of the analytical method 
for the detection and quantification of creatinine and caffeine in artificial samples. This method 
allowed for fast, direct and facile determinations of the two compounds which hold significant 
potential for analyzing real drugs or drug metabolites present in human urine samples and pave the 
way for future direct infusion mass spectrometry studies. 
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